- Latest available (Revised)
- Point in Time (01/04/2004)
- Original (As made)
Version Superseded: 18/05/2004
Point in time view as at 01/04/2004.
There are currently no known outstanding effects for the The Prescription Only Medicines (Human Use) Order 1997.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Articles 3(a), 5(1) and 10
Exemptions from the restrictions on the sale and supply of prescription only medicines | |||||
---|---|---|---|---|---|
Column 1 | Column 2 | Column 3 | Column 4 | Column 5 | |
Substance | Maximum strength | Route of administration, use or pharmaceutical form | Treatment limitations | Maximum quantity | |
[F1Acamprosate] | |||||
Acarbose | |||||
Acebutolol Hydrochloride | |||||
[F1Aceclofenac] | |||||
Acemetacin | |||||
Acetarsol | |||||
Acetazolamide | |||||
Acetazolamide Sodium | |||||
Acetohexamide | |||||
Acetylcholine Chloride | 0.2 per cent | External | |||
Acetylcysteine | |||||
Acipimox | |||||
Aciclovir | 5.0 per cent | External | Container or package containing not more than 2g of medicinal product | ||
For treatment of herpes simplex virus infections of the lips and face (Herpes labialis) | |||||
Acitretin | |||||
Aclarubicin Hydrochloride | |||||
Aconite | 1.3 per cent | External | |||
Acrivastine | 24 mg (MDD) | Container or package containing not more than 240mg of Acrivastine | |||
Acrosoxacin | |||||
Actinomycin C | |||||
Actinomycin D | |||||
[F2Adapalene] | |||||
Adenosine | |||||
Adrenaline | (1) By inhaler | ||||
(2) External [F3(except ophthalmic)] | |||||
Adrenaline Acid Tartrate | (1) By inhaler | ||||
(2) External | |||||
Adrenaline Hydrochloride | (1) By inhaler | ||||
(2) External | |||||
Adrenocortical Extract | |||||
Albendazole | |||||
Alclofenac | |||||
Alclometasone Dipropionate | |||||
Alcuronium Chloride | |||||
Aldesleukin | |||||
Aldosterone | |||||
[F1Alendronate Sodium] | |||||
Alfacalcidol | |||||
Alfuzosin Hydrochloride | |||||
Allergen Extracts | |||||
Allopurinol | |||||
Allyloestrenol | |||||
[F4Aloxiprin | (1) 620 mg | (1) Non-effervescent tablets and capsules | (1) The quantity sold or supplied in one container or package shall not exceed 32 | ||
The quantity of non-effervescent tablets, capsules or a combination of both sold or supplied to a person at any one time shall not exceed 100 | |||||
(2) All preparations other than non-effervescent tablets or capsules] | |||||
Alphadolone Acetate | |||||
Alphaxalone | |||||
Alprenolol | |||||
Alprenolol Hydrochloride | |||||
Alprostadil | |||||
Alseroxylon | |||||
[F2Altretamine] | |||||
Amantadine Hydrochloride | |||||
Ambenonium Chloride | |||||
Ambutonium Bromide | |||||
Amcinonide | |||||
Ametazole Hydrochloride | |||||
Amethocaine | Non-ophthalmic use | ||||
Amethocaine Gentisate | Non-ophthalmic use | ||||
Amethocaine Hydrochloride | Non-ophthalmic use | ||||
Amikacin Sulphate | |||||
Amiloride Hydrochloride | |||||
Aminocaproic Acid | |||||
Aminoglutethimide | |||||
Aminopterin Sodium | |||||
Amiodarone Hydrochloride | |||||
Amiphenazole Hydrochloride | |||||
[F5Amisulpride] | |||||
Amitriptyline | |||||
Amitriptyline Embonate | |||||
Amitriptyline Hydrochloride | |||||
Amlodipine Besylate | |||||
Ammonium Bromide | |||||
Amodiaquine Hydrochloride | |||||
Amorolfine Hydrochloride | |||||
Amoxapine | |||||
Amoxycillin | |||||
Amoxycillin Sodium | |||||
Amoxycillin Trihydrate | |||||
Amphomycin Calcium | |||||
Amphotericin | |||||
Ampicillin | |||||
Ampicillin Sodium | |||||
Ampicillin Trihydrate | |||||
Amsacrine | |||||
Amygdalin | |||||
Amyl Nitrite | |||||
Amylocaine Hydrochloride | Non-ophthalmic use | ||||
[F1Anastrozole] | |||||
Ancrod | |||||
Androsterone | |||||
Angiotensin Amide | |||||
Anistreplase | |||||
Anterior Pituitary Extract | |||||
Antimony Barium Tartrate | |||||
Antimony Dimercaptosuccinate | |||||
Antimony Lithium Thiomalate | |||||
Antimony Pentasulphide | |||||
Antimony Potassium Tartrate | |||||
Antimony Sodium Tartrate | |||||
Antimony Sodium Thioglycollate | |||||
Antimony Sulphate | |||||
Antimony Trichloride | |||||
Antimony Trioxide | |||||
Antimony Trisulphide | |||||
Apiol | |||||
Apomorphine | |||||
Apomorphine Hydrochloride | |||||
[F2Apraclonidine Hydrochloride] | |||||
Aprotinin | |||||
Arecoline Hydrobromide | |||||
Argipressin | |||||
Aristolochia | |||||
Aristolochia Clematitis | |||||
Aristolochia Contorta | |||||
Aristolochia Debelis | |||||
Aristolochia Fang-chi | |||||
Aristolochia Manshuriensis | |||||
Aristolochia Serpentaria | |||||
Arsenic | |||||
Arsenic Triiodide | |||||
Arsenic Trioxide | |||||
Arsphenamine | |||||
[F6Aspirin | [F7(1) 75mg] | [F7(1) Non-effervescent tablets and capsules] | [F7(1) The quantity sold or supplied in one container or package shall not exceed 100
| ||
[F9(2)] Non-effervescent tablets and capsules | [F9(2)] The quantity sold or supplied in one container or package shall not exceed 32 | ||||
[F9(3)] All preparations other than non-effervescent tablets or capsules |
| ||||
Astemizole | F10. . . | F10. . . | F10. . . | ||
F10. . . | |||||
F10. . . | |||||
Atenolol | |||||
Atracurium Besylate | |||||
Atropine | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 300mcg (MD) | ||||
1mg (MDD) | |||||
(2) External (except ophthalmic) | |||||
Atropine Methobromide | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 400mcg (MD) | ||||
1.3mg (MDD) | |||||
(2) External (except ophthalmic) | |||||
Atropine Methonitrate | Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 400mcg (MD) | ||||
1.3mg (MDD) | |||||
Atropine Oxide Hydrochloride | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 360mcg (MD) | ||||
1.2mg (MDD) 3 | |||||
(2) External (except ophthalmic) | |||||
Atropine Sulphate | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 360mcg (MD) | ||||
1.2mg (MDD) | |||||
(2) External (except ophthalmic) | |||||
Auranofin | |||||
Azapropazone | |||||
Azathioprine | |||||
Azathioprine Sodium | |||||
Azelaic Acid | |||||
Azelastine Hydrochloride | For nasal administration | 140mcg per nostril (MD) | Container or package containing not more than 5,040mcg of Azelastine Hydrochloride | ||
For the treatment of seasonal allergic rhinitis [F11or perennial allergic rhinitis] | 280mcg per nostril (MDD) | ||||
For use in adults and children not less than [F125 years] | |||||
As a non-aerosol, aqueous form | |||||
Azidocillin Potassium | |||||
Azithromycin | |||||
Azlocillin Sodium | |||||
Aztreonam | |||||
Bacampicillin Hydrochloride | |||||
Bacitracin | |||||
Bacitracin Methylene Disalicylate | |||||
Bacitracin Zinc | |||||
Baclofen | |||||
[F5Balsalazide Sodium] | |||||
Bambuterol Hydrochloride | |||||
Barium Carbonate | |||||
Barium Chloride | |||||
Barium Sulphide | |||||
Beclamide | |||||
Beclomethasone | |||||
Beclomethasone Dipropionate | For nasal administration (non-aerosol) | 100mcg per nostril (MD) | Container or package containing not more than [F1320,000 mcg] of Beclomethasone Dipropionate | ||
For the prevention and treatment of allergic rhinitis | 200 mcg per nostril (MDD) | ||||
[F14For a maximum period of 3 months] | |||||
[F15For use in persons aged 18 years and over] | |||||
Belladonna Herb | (1) Internal | (1) 1mg of the alkaloids (MDD) | |||
(2) External | |||||
Belladonna Root | (1) Internal | (1) 1mg of the alkaloids (MDD) | |||
(2) External | |||||
Bemegride | |||||
Bemegride Sodium | |||||
Benapryzine Hydrochloride | |||||
Bendrofluazide | |||||
Benethamine Penicillin | |||||
Benoxaprofen | |||||
Benperidol | |||||
[F5Benserazide] | |||||
Benserazide Hydrochloride | |||||
Bentiromide | |||||
Benzathine Penicillin | |||||
Benzbromarone | |||||
Benzhexol Hydrochloride | |||||
Benzilonium Bromide | |||||
Benzocaine | Any use except ophthalmic use | ||||
Benzoctamine Hydrochloride | |||||
Benzoyl Peroxide | 10.0 per cent | External | |||
N-Benzoyl Sulphanilamide | |||||
Benzquinamide | |||||
Benzquinamide Hydrochloride | |||||
Benzthiazide | |||||
Benztropine Mesylate | |||||
Benzylpenicillin Calcium | |||||
Benzylpenicillin Potassium | |||||
Benzylpenicillin Sodium | |||||
Beractant | |||||
Betahistine Hydrochloride | |||||
Betamethasone | |||||
Betamethasone Adamantoate | |||||
Betamethasone Benzoate | |||||
Betamethasone Dipropionate | |||||
Betamethasone Sodium Phosphate | |||||
Betamethasone Valerate | |||||
Betaxolol Hydrochloride | |||||
Bethanechol Chloride | |||||
Bethanidine Sulphate | |||||
Bezafibrate | |||||
[F2Bicalutamide] | |||||
Biperiden Hydrochloride | |||||
Biperiden Lactate | |||||
Bismuth Glycollylarsanilate | |||||
Bisoprolol Fumarate | |||||
Bleomycin | |||||
Bleomycin Sulphate | |||||
Bretylium Tosylate | |||||
[F5Brimonidine Tartrate] | |||||
Bromhexine Hydrochloride | |||||
Bromocriptine Mesylate | |||||
Bromperidol | |||||
Bromvaletone | |||||
Brotizolam | |||||
Budesonide | For nasal administration | 200mcg per nostril (MD) | Container or package containing not more than 10mg of Budesonide | ||
For the prevention or treatment of seasonal allergic rhinitis | [F14For a maximum period of 3 months] | ||||
200 mcg per nostril (MDD) | |||||
[F15For use in persons aged 18 years and over] | |||||
As a non-aerosol, aqueous form | |||||
Bufexamac | |||||
Bumetanide | |||||
Buphenine Hydrochloride | 6mg (MD) | ||||
18mg (MDD) | |||||
Bupivacaine | Any use except ophthalmic use | ||||
Bupivacaine Hydrochloride | Any use except ophthalmic use | ||||
Buserelin Acetate | |||||
Buspirone Hydrochloride | |||||
Busulphan | |||||
Butacaine Sulphate | Any use except ophthalmic use | ||||
Butorphanol Tartrate | |||||
Butriptyline Hydrochloride | |||||
[F16Cabergoline] | |||||
Calcipotriol | |||||
[F2Calcipotriol Hydrate] | |||||
Calcitonin | |||||
Calcitriol | |||||
Calcium Amphomycin | |||||
Calcium Benzamidosalicylate | |||||
Calcium Bromide | |||||
Calcium Bromidolactobionate | |||||
Calcium Carbimide | |||||
Calcium Folinate | |||||
Calcium Metrizoate | |||||
Calcium Sulphaloxate | |||||
[F17Candesartan Cilexetil] | |||||
Candicidin | |||||
Canrenoic Acid | |||||
Cantharidin | 0.01 per cent | External | |||
Capreomycin Sulphate | |||||
Captopril | |||||
Carbachol | |||||
Carbamazepine | |||||
Carbaryl | |||||
[F5Carbasalate Calcium] | |||||
Carbenicillin Sodium | |||||
Carbenoxolone Sodium | (1) Pellet | (1) 5mg (MD) | |||
25mg (MDD) | |||||
(2) 2.0 per cent | (2) Gel | ||||
(3) 1.0 per cent | (3) Granules for mouthwash in adults and children not less than 12 years | (3) 20mg (MD) | (3) Container or package containing not more than [F18560mg] of Carbenoxolone Sodium | ||
80mg (MDD) | |||||
Carbidopa | |||||
Carbimazole | |||||
Carbocisteine | |||||
Carbon Tetrachloride | |||||
Carboplatin | |||||
Carboprost Trometamol | |||||
Carbuterol Hydrochloride | |||||
Carfecillin Sodium | |||||
Carindacillin Sodium | |||||
Carisoprodol | |||||
Carmustine | |||||
Carperidine | |||||
Carteolol Hydrochloride | |||||
Cefaclor | |||||
Cefadroxil | |||||
Cefazedone Sodium | |||||
[F5Cefdinir] | |||||
Cefixime | |||||
Cefodizime Sodium | |||||
Cefotaxime Sodium | |||||
Cefoxitin Sodium | |||||
Cefpodoxime Proxetil | |||||
[F16Cefprozil] | |||||
Cefsulodin Sodium | |||||
Ceftazidime | |||||
Ceftizoxime Sodium | |||||
Ceftriaxone Sodium | |||||
Cefuroxime Axetil | |||||
Cefuroxime Sodium | |||||
Celiprolol Hydrochloride | |||||
Cephalexin | |||||
Cephalexin Sodium | |||||
Cephaloridine | |||||
Cephalothin Sodium | |||||
Cephamandole Nafate | |||||
Cephazolin Sodium | |||||
Cephradine | |||||
Cerium Oxalate | |||||
Cerivastatin | |||||
[F5Cerivastatin Sodium] | |||||
Ceruletide Diethylamine | |||||
Cetirizine Hydrochloride | 10mg (MDD) | F19. . . | |||
Chenodeoxycholic Acid | |||||
Chloral Hydrate | External | ||||
Chlorambucil | |||||
Chloramphenicol | |||||
Chloramphenicol Cinnamate | |||||
Chloramphenicol Palmitate | |||||
Chloramphenicol Sodium Succinate | |||||
Chlorhexadol | |||||
Chlormadinone Acetate | |||||
Chlormerodrin | |||||
Chlormethiazole | |||||
Chlormethiazole Edisylate | |||||
Chlormezanone | |||||
Chloroform(1) | (1) 5.0 per cent | (1) Internal | |||
(2) External | |||||
Chloroquine Phosphate | Prophylaxis of malaria | ||||
Chloroquine Sulphate | Prophylaxis of malaria | ||||
Chlorothiazide | |||||
Chlorotrianisene | |||||
Chlorphenoxamine Hydrochloride | |||||
Chlorpromazine | |||||
Chlorpromazine Embonate | |||||
Chlorpromazine Hydrochloride | |||||
Chlorpropamide | |||||
Chlorprothixene | |||||
Chlorprothixene Hydrochloride | |||||
Chlortetracycline | |||||
Chlortetracycline Calcium | |||||
Chlortetracycline Hydrochloride | |||||
Chlorthalidone | |||||
Chlorzoxazone | |||||
Cholestyramine | |||||
Ciclacillin | |||||
Ciclobendazole | |||||
Cilastatin Sodium | |||||
Cilazapril | |||||
Cimetidine | (a) For the short-term symptomatic relief of heartburn, dyspepsia, indigestion, acid indigestion and hyperacidity and for the prophylaxis of meal-induced heartburn | (a) 200mg (MD) | |||
800mg (MDD) | |||||
For a maximum period of 14 days | |||||
(b) For the prophylactic management of nocturnal heartburn by a single dose taken at night | (b) 100mg (MD) to be taken as a single dose at night | ||||
For a maximum period of 14 days | |||||
Cimetidine Hydrochloride | |||||
Cinchocaine | 3.0 per cent | Non-ophthalmic use | |||
Cinchocaine Hydrochloride | Equivalent of 3.0 per cent of Cinchocaine | Non-ophthalmic use | |||
Cinchophen | |||||
Cinoxacin | |||||
Ciprofibrate | |||||
Ciprofloxacin | |||||
Ciprofloxacin Hydrochloride | |||||
Cisapride | |||||
Cisplatin | |||||
[F2Citalopram Hydrobromide] | |||||
Clarithromycin | |||||
Clavulanic Acid | |||||
Clidinium Bromide | |||||
Clindamycin | |||||
Clindamycin Hydrochloride | |||||
Clindamycin Palmitate Hydrochloride | |||||
Clindamycin Phosphate | |||||
Clioquinol | (1) External (other than treatment of mouth ulcers) | ||||
(2) 35mg | (2) Treatment of mouth ulcers | (2) 350mg (MDD) | |||
Clobetasol Propionate | |||||
Clobetasone Butyrate | [F200.05 per cent] | [F20Cream for use in adults and in children aged 12 years and over, for external use for the short term symptomatic treatment and control of patches of eczema and dermatitis (excluding seborrhoeic dermatitis)] | [F20Container or package containing not more than 15g of medicinal product] | ||
Clofazimine | |||||
Clofibrate | |||||
Clomiphene Citrate | |||||
Clomipramine | |||||
Clomipramine Hydrochloride | |||||
Clomocycline | |||||
Clomocycline Sodium | |||||
Clonidine | |||||
Clonidine Hydrochloride | |||||
Clopamide | |||||
Clopenthixol Decanoate | |||||
Clopenthixol Hydrochloride | |||||
Clorexolone | |||||
Clotrimazole | External but in the case of vaginal use only external use for the treatment of vaginal candidiasis | ||||
Cloxacillin Benzathine | |||||
Cloxacillin Sodium | |||||
Clozapine | |||||
Cocculus Indicus | |||||
Co-dergocrine Mesylate | |||||
Colaspase | |||||
Colchicine | |||||
Colestipol Hydrochloride | |||||
Colfosceril Palmitate | |||||
Colistin Sulphate | |||||
Colistin Sulphomethate | |||||
Colistin Sulphomethate Sodium | |||||
Coniine | |||||
Conium Leaf | 7.0 per cent | External | |||
Corticotrophin | |||||
Cortisone | |||||
Cortisone Acetate | |||||
Co-tetroxazine | |||||
Co-trimoxazole | |||||
Cropropamide | |||||
Crotethamide | |||||
Croton Oil | |||||
Croton Seed | |||||
Curare | |||||
Cyclofenil | |||||
Cyclopenthiazide | |||||
Cyclopentolate Hydrochloride | |||||
Cyclophosphamide | |||||
Cycloserine | |||||
Cyclosporin | |||||
Cyclothiazide | |||||
Cyproterone Acetate | |||||
Cytarabine | |||||
Cytarabine Hydrochloride | |||||
Dacarbazine | |||||
Dalteparin Sodium | |||||
Danazol | |||||
Danthron | |||||
Dantrolene Sodium | |||||
Dapsone | |||||
Dapsone Ethane Ortho Sulphonate | |||||
Daunorubicin Hydrochloride | |||||
Deanol Bitartrate | 26mg (MDD) | ||||
Debrisoquine Sulphate | |||||
Demecarium Bromide | |||||
Demeclocycline | |||||
Demeclocycline Calcium | |||||
Demeclocycline Hydrochloride | |||||
Deoxycortone Acetate | |||||
Deoxycortone Pivalate | |||||
Deptropine Citrate | |||||
Dequalinium Chloride | (1) 0.25mg | (1) Internal: throat lozenges or throat pastilles | |||
(2) 1.0 per cent | (2) External: paint | ||||
Deserpidine | |||||
Desferrioxamine Mesylate | |||||
Desflurane | |||||
Desipramine Hydrochloride | |||||
Deslanoside | |||||
Desmopressin | |||||
Desmopressin Acetate | |||||
Desogestrel | |||||
Desonide | |||||
Desoxymethasone | |||||
Dexamethasone | |||||
Dexamethasone Acetate | |||||
Dexamethasone Isonicotinate | |||||
Dexamethasone Phenylpropionate | |||||
Dexamethasone Pivalate | |||||
Dexamethasone Sodium Metasulphobenzoate | |||||
Dexamethasone Sodium Phosphate | |||||
Dexamethasone Troxundate | |||||
Dexfenfluramine Hydrochloride | |||||
Dextromethorphan Hydrobromide | Internal | (a) In the case of a prolonged release preparation: equivalent of 30mg of Dextromethorphan (MD) | |||
equivalent of 75mg of Dextromethorphan (MDD) | |||||
(b) in any other case: equivalent of 15mg of Dextromethorphan (MD) | |||||
equivalent of 75mg of Dextromethorphan (MDD) | |||||
Dextrothyroxine Sodium | |||||
Diazoxide | |||||
Dibenzepin Hydrochloride | |||||
Dichloralphenazone | |||||
Dichlorphenamide | |||||
Diclofenac Diethylammonium | 1.16 per cent | External | For maximum period of 7 days | Container or package containing not more than 30g of medicinal product | |
For local symptomatic relief of pain and inflammation in trauma of the tendons, ligaments, muscles and joints and in localised forms of soft tissue rheumatism | |||||
For use in adults and children not less than 12 years | |||||
Diclofenac Potassium | |||||
Diclofenac Sodium | |||||
Dicyclomine Hydrochloride | 10mg (MD) | ||||
60mg (MDD) | |||||
[F1Didanosine] | |||||
Dienoestrol | |||||
Diethanolamine Fusidate | |||||
Diflucortolone Valerate | |||||
Diflunisal | |||||
Digitalin | |||||
Digitalis Leaf | |||||
Digitalis Prepared | |||||
Digitoxin | |||||
Digoxin | |||||
Dihydralazine Sulphate | |||||
Dihydroergotamine Mesylate | |||||
Dihydrostreptomycin | |||||
Dihydrostreptomycin Sulphate | |||||
Diloxanide Furoate | |||||
Diltiazem Hydrochloride | |||||
Dimercaprol | |||||
Dimethisoquin Hydrochloride | Non-ophthalmic use | ||||
Dimethisterone | |||||
Dimethothiazine Mesylate | |||||
Dimethyl Sulphoxide | |||||
Dimethyltubocurarine Bromide | |||||
Dimethyltubocurarine Chloride | |||||
Dimethyltubocurarine Iodide | |||||
Dinoprost | |||||
Dinoprost Trometamol | |||||
Dinoprostone | |||||
[F4Diphenhydramine Hydrochloride | All preparations except liquid-filled capsules] | ||||
[F21Diphenoxylate Hydrochloride] | [F212.5 mg] | [F21In combination with Atropine Sulphate for short term use as an adjunctive therapy to appropriate rehydration in acute diarrhoea | [F2125 mg (MDD)] | [F21Container or package containing not more than 20 tablets] | |
For use in persons aged 16 years and over | |||||
Tablets] | |||||
Dipivefrin Hydrochloride | |||||
Dipyridamole | |||||
Disodium Etidronate | |||||
Disodium Pamidronate | |||||
Disopyramide | |||||
Disopyramide Phosphate | |||||
Distigmine Bromide | |||||
Disulfiram | |||||
Dithranol | 1.0 per cent | ||||
Dobutamine Hydrochloride | |||||
[F21Dolasetron Mesilate] | |||||
Domperidone | [F22For the relief of post-prandial symptoms of excessive fullness, nausea, epigastric bloating and belching, occasionally accompanied by epigastric discomfort and heartburn] | [F2210mg of Domperidone (MD)] | [F22Container or package containing not more than 200mg of Domperidone] | ||
[F2240mg of Domperidone (MDD)] | |||||
Domperidone Maleate | [F23For the relief of post-prandial symptoms of excessive fullness, nausea, epigastric bloating and belching, occasionally accompanied by epigastric discomfort and heartburn,] | [F2410 mg of Domperidone as Domperidone Maleate (MD)] | [F23Container or package containing not more than [F25200mg] of Domperidone as Domperidone Maleate;] | ||
[F2440 mg of Domperidone as Domperidone Maleate (MDD)] | |||||
[F5Donepezil Hydrochloride] | |||||
Dopamine Hydrochloride | |||||
Dopexamine Hydrochloride | |||||
[F2Dorzolamide Hydrochloride] | |||||
Dothiepin | |||||
Dothiepin Hydrochloride | |||||
Doxapram Hydrochloride | |||||
Doxazosin Mesylate | |||||
Doxepin Hydrochloride | |||||
Doxorubicin | |||||
Doxorubicin Hydrochloride | |||||
Doxycycline | |||||
Doxycycline Calcium Chelate | |||||
Doxycycline Hydrochloride | |||||
Droperidol | |||||
Dydrogesterone | |||||
Dyflos | |||||
Econazole | External but in the case of vaginal use only external use for the treatment of vaginal candidiasis | ||||
Econazole Nitrate | External but in the case of vaginal use only external use for the treatment of vaginal candidiasis | ||||
Ecothiopate Iodide | |||||
Edrophonium Chloride | |||||
Eflornithine Hydrochloride | |||||
[F1Eformoterol Fumarate] | |||||
Embutramide | |||||
Emepronium Bromide | |||||
Emetine | 1.0 per cent | ||||
Emetine Bismuth Iodide | |||||
Emetine Hydrochloride | Equivalent of 1.0 per cent of Emetine | ||||
Enalapril Maleate | |||||
Encephalitis Virus, Tick-borne, Cent Eur | |||||
Enoxacin | |||||
Enoxaparin Sodium | |||||
Enoximone | |||||
Ephedrine | (1) Internal (other than nasal sprays or nasal drops) | (1) 30mg (MD) | |||
60mg (MDD) | |||||
(2) 2.0 per cent | (2) Nasal sprays or nasal drops | ||||
(3) External | |||||
Ephedrine Hydrochloride | (1) Internal (other than nasal sprays or nasal drops) | (1) Equivalent of 30mg of Ephedrine (MD) | |||
Equivalent of 60mg of Ephedrine (MDD) | |||||
(2) Equivalent of 2.0 per cent of Ephedrine | (2) Nasal sprays or nasal drops | ||||
(3) External | |||||
Ephedrine Sulphate | (1) Internal (other than nasal sprays or nasal drops) | (1) Equivalent of 30mg of Ephedrine (MD) | |||
Equivalent of 60mg of Ephedrine (MDD) | |||||
(2) Equivalent of 2.0 per cent of Ephedrine | (2) Nasal sprays or nasal drops | ||||
(3) External | |||||
Epicillin | |||||
Epirubicin | |||||
Epirubicin Hydrochloride | |||||
Epithiazide | |||||
Epoetin Alfa | |||||
Epoetin Beta | |||||
Epoprostenol Sodium | |||||
Ergometrine Maleate | |||||
Ergometrine Tartrate | |||||
Ergot, Prepared | |||||
Ergotamine Tartrate | |||||
Erythromycin | |||||
Erythromycin Estolate | |||||
Erythromycin Ethylcarbonate | |||||
Erythromycin Ethyl Succinate | |||||
Erythromycin Lactobionate | |||||
Erythromycin Phosphate | |||||
Erythromycin Stearate | |||||
Erythromycin Thiocyanate | |||||
Esmolol Hydrochloride | |||||
Estramustine Phosphate | |||||
[F26Estramustine Sodium Phosphate] | |||||
Etafedrine Hydrochloride | |||||
Ethacrynic Acid | |||||
Ethambutol Hydrochloride | |||||
Ethamivan | |||||
Ethamsylate | |||||
Ethiazide | |||||
Ethinyl Androstenediol | |||||
Ethinyloestradiol | |||||
Ethionamide | |||||
Ethisterone | |||||
Ethoglucid | |||||
Ethoheptazine Citrate | |||||
Ethopropazine Hydrochloride | |||||
Ethosuximide | |||||
Ethotoin | |||||
Ethyl Biscoumacetate | |||||
Ethynodiol Diacetate | |||||
Etodolac | |||||
Etomidate | |||||
Etomidate Hydrochloride | |||||
Etoposide | |||||
Etretinate | |||||
[F2Exemestane] | |||||
Famciclovir | |||||
Famotidine | For the short-term symptomatic relief of heartburn, dyspepsia, indigestion, acid indigestion and hyperacidity, and prevention of these symptoms when associated with food and drink, including nocturnal symptoms | 10mg (MD) | |||
20mg (MDD) | |||||
For maximum period of 14 days | |||||
Fazadinium Bromide | |||||
Felbinac | 3.17 per cent | External | For maximum period of 7 days | Container or package containing not more than [F2750g] of medicinal product | |
[F28For the relief of rheumatic pain, pain of non-serious arthritic conditions and soft tissue injuries such as sprains, strains and contusions] | |||||
For use in adults and children not less than 12 years | |||||
Felodipine | |||||
Felypressin | |||||
Fenbufen | |||||
Fenclofenac | |||||
Fenfluramine Hydrochloride | |||||
Fenofibrate | |||||
Fenoprofen | |||||
Fenoprofen Calcium | |||||
Fenoterol Hydrobromide | |||||
Fenticonazole Nitrate | [F20External use (but in the case of vaginal use, only for the treatment of vaginal candidiasis)] | ||||
Feprazone | |||||
Ferrous Arsenate | |||||
[F2Ferumoxsil] | |||||
[F5Fexofenadine Hydrochloride] | |||||
Filgrastim | |||||
Finasteride | |||||
Flavoxate Hydrochloride | |||||
Flecainide Acetate | |||||
Flosequinan | |||||
Fluanisone | |||||
Flubendazole | |||||
Fluclorolone Acetonide | |||||
Flucloxacillin Magnesium | |||||
Flucloxacillin Sodium | |||||
Fluconazole | For oral administration for the treatment of vaginal candidiasis [F29or associated candidal balanitis] in persons aged not less than 16 but less than 60 years | 150mg (MD) | Container or package containing not more than 150mg of Fluconazole | ||
Flucytosine | |||||
Fludrocortisone Acetate | |||||
Flufenamic Acid | |||||
Flumazenil | |||||
Flumethasone | |||||
Flumethasone Pivalate | |||||
Flunisolide | 0.025 per cent | (a) For the prevention and treatment of seasonal allergic rhinitis, including hay fever | (a) 50mcg per nostril (MD) | (a) Container or package containing not more than 6,000mcg of Flunisolide | |
100mcg per nostril (MDD) | |||||
[F30For use in persons aged 18 years and over] | [F31For a maximum period of 3 months] | ||||
In the form of a non-pressurised nasal spray | |||||
F32... | F32... | F32... | |||
F32. . . | |||||
F32. . . | |||||
F32. . . | |||||
Fluocinolone Acetonide | |||||
Fluocinonide | |||||
Fluocortin Butyl | |||||
Fluocortolone | |||||
Fluocortolone Hexanoate | |||||
Fluocortolone Pivalate | |||||
Fluorescein Dilaurate | |||||
Fluorometholone | |||||
Fluorouracil | |||||
Fluorouracil Trometamol | |||||
Fluoxetine Hydrochloride | |||||
Flupenthixol Decanoate | |||||
Flupenthixol Hydrochloride | |||||
Fluperolone Acetate | |||||
Fluphenazine Decanoate | |||||
Fluphenazine Enanthate | |||||
Fluphenazine Hydrochloride | |||||
Fluprednidene Acetate | |||||
Fluprednisolone | |||||
Fluprostenol Sodium | |||||
Flurandrenolone | |||||
Flurbiprofen | [F338.75 mg] | [F34Throat lozenges] | [F3543.75 mg (MDD)] | [F36Container or package containing not more than 140 mg of Flurbiprofen] | |
Flurbiprofen Sodium | |||||
Fluspirilene | |||||
Flutamide | |||||
Fluticasone Propionate | |||||
[F5Flutrimazole] | |||||
Fluvastatin Sodium | |||||
Fluvoxamine Maleate | |||||
Folic Acic | 500mcg (MDD) | ||||
Formestane | |||||
Formocortal | |||||
Foscarnet Sodium | |||||
Fosfestrol Sodium | |||||
Fosfomycin Trometamol | |||||
Fosinopril Sodium | |||||
Framycetin Sulphate | |||||
Frusemide | |||||
Furazolidone | |||||
Fusafungine | |||||
Fusidic Acid | |||||
Gabapentin | |||||
Gadoteridol | |||||
Gallamine Triethiodide | |||||
Ganciclovir | |||||
Ganciclovir Sodium | |||||
Gelsemine | 0.1 per cent | ||||
Gelsemium | 25mg (MD) | ||||
75mg (MDD) | |||||
Gemeprost | |||||
Gemfibrozil | |||||
Gentamicin | |||||
Gentamicin Sulphate | |||||
Gestodene | |||||
Gestrinone | |||||
Gestronol | |||||
Gestronol Hexanoate | |||||
Glibenclamide | |||||
Glibornuride | |||||
Gliclazide | |||||
Glipizide | |||||
Gliquidone | |||||
Glisoxepide | |||||
Glucagon | |||||
Glycopyrronium Bromide | 1mg (MD) | ||||
2mg (MDD) | |||||
Glymidine | |||||
Gonadorelin | |||||
Goserelin Acetate | |||||
Gramicidin | 0.2 per cent | External | |||
Granisetron Hydrochloride | |||||
Griseofulvin | |||||
Growth Hormone | |||||
Guanethidine Monosulphate | |||||
Guanfacine Hydrochloride | |||||
Guanoclor Sulphate | |||||
Guanoxan Sulphate | |||||
Halcinonide | |||||
Halofantrine Hydrochloride | |||||
Haloperidol | |||||
Haloperidol Decanoate | |||||
Heparin | External | ||||
Heparin Calcium | External | ||||
Heparin Sodium | |||||
Hexachlorophane | External | ||||
(a) 2.0 per cent | (a) Soaps | ||||
(b) 0.1 per cent | (b) Aerosols | ||||
(c) 0.75 per cent | (c) preparations other than soaps and aerosols | ||||
Hexamine Phenylcinchoninate | |||||
Hexobarbitone | |||||
Hexobarbitone Sodium | |||||
Hexoestrol | |||||
Hexoestrol Dipropionate | |||||
L-Histidine Hydrochloride | Dietary supplementation | ||||
Homatropine | (1) Internal | (1) 0.15mg (MD) | |||
0.45mg (MDD) | |||||
(2) External (except ophthalmic) | |||||
Homatropine Hydrobromide | 0.2mg (MD) | ||||
0.6mg (MDD) | |||||
Homatropine Methylbromide | 2mg (MD) | ||||
6mg (MDD) | |||||
Hydralazine Hydrochloride | |||||
Hydrargaphen | Local application to skin | ||||
Hydrobromic Acid | |||||
Hydrochlorothiazide | |||||
Hydrocortisone | [F37(1) 0.5 per cent] | [F37(1) External (a) For use in combination with Nystatin of maximum strength 3.0 per cent for intertrigo (b) For use in adults and children not less than 10 years] | [F37(1) Container or package containing not more than 15g of medicinal product] | ||
[F38(2)] 1.0 per cent | [F38(2)] External (a) For use either alone or in conjunction with Crotamiton in irritant dermatitis, contact allergic dermatitis, insect bite reactions, mild to moderate eczema, and either in combination with Clotrimazole [F39or Miconazole Nitrate] for athlete’s foot and candidal intertrigo or in combination with lignocaine for anal and perianal itch associated with haemorrhoids (b) For use in adults and children not less than 10 years (c) Cream ointment or spray | [F38(2)] Container or package containing not more than 15g of medicinal product (cream or ointment) or 30ml (spray) | |||
Hydrocortisone Acetate | Equivalent to 1.0 per cent Hydrocortisone | External | |||
For use in irritant dermatitis, contact allergic dermatitis, insect bite reactions, mild to moderate eczema, and in combination with one or more of the following: Benzyl Benzoate, Bismuth Oxide, Bismuth Subgallate, Peru Balsam, Pramoxine Hydrochloride, Zinc Oxide, for haemorrhoids [F40or in combination with Miconazole Nitrate, for athlete’s foot and candidal intertrigo] | Container or package containing not more than 15g of medicinal product | ||||
In the case of suppositories, container or package containing no more than 12 | |||||
For use in adults and children not less than 10 years | |||||
Cream, ointment or suppositories | |||||
Hydrocortisone Butyrate | |||||
Hydrocortisone Caprylate | |||||
Hydrocortisone Hydrogen Succinate | |||||
Hydrocortisone Sodium Phosphate | |||||
Hydrocortisone Sodium Succinate | Equivalent to 2.5mg Hydrocortisone | External | Container or package containing not more than equivalent to 50mg of Hydrocortisone | ||
For aphthous ulceration of the mouth for adults and children not less than 12 years | |||||
In the form of pellets | |||||
[F4Hydrocyanic Acid] | |||||
Hydroflumethiazide | |||||
Hydroxychloroquine Sulphate | Prophylaxis of malaria | ||||
Hydroxyprogesterone | |||||
Hydroxyprogesterone Enanthate | |||||
Hydroxyprogesterone Hexanoate | |||||
Hydroxyurea | |||||
Hydroxyzine Embonate | |||||
Hydroxyzine Hydrochloride | (a) For the management of pruritis associated with acute or chronic urticaria or atopic dermatitis or contact dermatitis, in adults and in children not less than 12 years | (a) 25mg (MD) | (a) Container or package containing not more than 750mg of Hydroxyzine Hydrochloride | ||
75mg (MDD) | |||||
(b) For the management of pruritis associated with acute or chronic urticaria or atopic dermatitis or contact dermatitis, in children not less than 6 years but less than 12 years | (b) 25 mg (MD) | (b) Container or package containing not more than 750mg of Hydroxyzine Hydrochloride | |||
50mg (MDD) | |||||
Hyoscine | (1) 0.15 per cent | (1) Internal | |||
(2) External (except ophthalmic) | |||||
Hyoscine Butylbromide | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 20mg (MD) | (b) Container or package containing not more than 240mg of Hyoscine Butylbromide | |||
80mg (MDD) | |||||
(2) External | |||||
Hyoscine Hydrobromide | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 300mcg (MD) | ||||
900mcg (MDD) | |||||
(2) External (except ophthalmic) | |||||
Hyoscine Methobromide | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 2.5mg (MD) | ||||
7.5mg (MDD) | |||||
(2) External | |||||
Hyoscine Methonitrate | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 2.5mg (MD) | ||||
7.5mg (MDD) | |||||
(2) External | |||||
Hyoscyamine | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) 300mcg (MD) | ||||
1mg (MDD) | |||||
(2) External | |||||
Hyoscyamine Hydrobromide | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) Equivalent of 300mcg of Hyoscyamine (MD) | ||||
Equivalent of 1mg of Hyoscyamine (MDD) | |||||
(2) External | |||||
Hyoscyamine Sulphate | (1) Internal | ||||
(a) by inhaler | |||||
(b) otherwise than by inhaler | (b) Equivalent of 300mcg of Hyoscyamine (MD) | ||||
Equivalent of 1mg of Hyoscyamine (MDD) | |||||
(2) External | |||||
Ibuprofen | Rheumatic and muscular pain, pain of non-serious arthritic conditions, backache, neuralgia, migraine, headache, dental pain, dysmenorrhoea, feverishness, symptoms of colds and influenza | ||||
(1) Internal | (1)(a) In the case of a prolonged release preparation 600mg (MD) | ||||
1,200mg (MDD) | |||||
(b) in any other case 400mg (MD) | |||||
1,200mg (MDD) | |||||
(2) 5.0 per cent | (2) External | ||||
[F41(3) 10.0 per cent] | [F41(3) External] | [F41(3) 125 mg (MD) 500 mg (MDD)] | [F41(3) Container or package containing not more than [F4250g] of medicinal product] | ||
[F4Ibuprofen Lysine | Rheumatic and muscular pain, pain of non-serious arthritic conditions, backache, neuralgia, migraine, headache, dental pain, dysmenorrhoea, feverishness, symptoms of colds and influenza | (a) in the case of a prolonged release preparation 600 mg (MD) 1,200 mg (MDD) | |||
Internal | (b) in any other case 400 mg (MD) 1,200 mg (MDD)] | ||||
Idarubicin Hydrochloride | |||||
Idoxuridine | |||||
Ifosfamide | |||||
Ignatius Bean | |||||
[F1Imidapril Hydrochloride] | |||||
Imipenem Hydrochloride | |||||
Imipramine | |||||
Imipramine Hydrochloride | |||||
Imipramine Ion Exchange Resin Bound Salt or Complex | |||||
[F16Indapamide] | |||||
Indapamide Hemihydrate | |||||
Indomethacin | |||||
Indomethacin Sodium | |||||
Indoprofen | |||||
Indoramin Hydrochloride | |||||
Inosine Pranobex | |||||
[F43Insulin] | |||||
Iodamide | |||||
Iodamide Meglumine | |||||
Iodamide Sodium | |||||
Iohexol | |||||
Iomeprol | |||||
Iopamidol | |||||
Iopentol | |||||
Iothalamic Acid | |||||
Ioversol | |||||
Ioxaglic Acid | |||||
Ipratropium Bromide | |||||
Iprindole Hydrochloride | |||||
Iproniazid Phosphate | |||||
[F5Irbesartan] | |||||
Isoaminile | |||||
Isoaminile Citrate | |||||
Isocarboxazid | |||||
Isoconazole Nitrate | External but in the case of vaginal use only external use for the treatment of vaginal candidiasis | ||||
Isoetharine | |||||
Isoetharine Hydrochloride | |||||
Isoetharine Mesylate | |||||
Isoniazid | |||||
Isoprenaline Hydrochloride | |||||
Isoprenaline Sulphate | |||||
Isopropamide Iodide | Equivalent of 2.5mg of Isopropamide ion (MD) | ||||
Equivalent of 5.0mg of Isopropamide ion (MDD) | |||||
Isotretinoin | |||||
Isradipine | |||||
Itraconazole | |||||
Jaborandi | External | ||||
Kanamycin Acid Sulphate | |||||
Kanamycin Sulphate | |||||
Ketamine Hydrochloride | |||||
Ketoconazole | 2.0 per cent | [F44(a)] [F45External] | [F44(a)] Maximum frequency of application of once every 3 days | [F44(a)] Container or package containing not more than 120ml of medicinal product and containing not more than 2,400mg of Ketoconazole | |
For the prevention and treatment of dandruff and seborrhoeic dermatitis of the scalp | |||||
In the form of a shampoo | |||||
[F46(b) For the treatment of the following mycotic infections of the skin: tinea pedis, tinea cruris and candidal intertrigo] | |||||
Ketoprofen | 2.5 per cent | External | For maximum period of 7 days | Container or package containing not more than 30g of medicinal product | |
For rheumatic and muscular pain in adults and children not less than 12 | |||||
Ketorolac Trometamol | |||||
Ketotifen Fumarate | |||||
Labetalol Hydrocholoride | |||||
Lachesine Chloride | |||||
Lacidipine | |||||
Lamotrigine | |||||
Lanatoside C | |||||
Lanatoside Complex A, B and C | |||||
[F16Lansoprazole] | |||||
Latamoxef Disodium | |||||
[F16Lercanidipine Hydrochloride] | |||||
Levallorphan Tartrate | |||||
Levobunolol Hydrochloride | |||||
[F4Levocabastine Hydrochloride | Equivalent of 0.05 per cent Levocabastine | (1) Nasal sprays | (1) Container or package containing not more than 10 ml of medicinal product | ||
For the symptomatic treatment of seasonal allergic rhinitis | |||||
(2) Aqueous eye drops | (2) Container or package containing not more than 4 ml of medicinal product] | ||||
For the symptomatic treatment of seasonal allergic conjunctivitis | |||||
[F47Levocarnitine] | [F47For dietary supplementation] | ||||
Levodopa | |||||
[F5Levofloxacin] | |||||
Levonorgestrel | [F480.75mg] | [F48for use as an emergency contraceptive in women aged 16 years and over] | |||
Lidoflazine | |||||
Lignocaine | Non-ophthalmic use | ||||
Lignocaine Hydrochloride | Non-ophthalmic use | ||||
Lincomycin | |||||
Lincomycin Hydrochloride | |||||
Liothyronine Sodium | |||||
Lisinopril | |||||
Lithium Carbonate | Equivalent of 5mg of Lithium (MD) | ||||
Equivalent of 15mg of Lithium (MDD) | |||||
Lithium Citrate | |||||
Lithium Succinate | |||||
Lithium Sulphate | Equivalent of 5mg of Lithium (MD) | ||||
Equivalent of 15mg of Lithium (MDD) | |||||
Lobeline | (1) Internal | (1) 3mg (MD) | |||
9mg (MDD) | |||||
(2) External | |||||
Lobeline Hydrochloride | (1) Internal | (1) Equivalent of 3mg of Lobeline (MD) | |||
Equivalent of 9mg of Lobeline (MDD) | |||||
(2) External | |||||
Lobeline Sulphate | (1) Internal | (1) Equivalent of 3mg of Lobeline (MD) | |||
Equivalent of 9mg of Lobeline (MDD) | |||||
(2) External | |||||
Lodoxamide Trometamol | [F49equivalent of 0.1 per cent Lodoxamide] | [F50For the treatment of ocular signs and symptoms of allergic conjunctivitis, in adults and in children aged 4 years and over] | |||
Lofepramine | |||||
Lofepramine Hydrochloride | |||||
Lofexidine Hydrochloride | |||||
Lomefloxacin Hydrochloride | |||||
Lomustine | |||||
Loperamide Hydrochloride | Treatment of acute diarrhoea | ||||
Loratidine | 10mg (MDD) | F51. . . | |||
[F17Lornoxicam] | |||||
[F17Losartan Potassium] | |||||
Loxapine Succinate | |||||
Lung Surfactant Porcine | |||||
Luteinising Hormone | |||||
Lymecycline | |||||
Lynoestrenol | |||||
Lypressin | |||||
Lysuride Maleate | |||||
Mafenide | |||||
Mafenide Acetate | |||||
Mafenide Hydrochloride | |||||
Mafenide Propionate | 5.0 per cent | Eye drops | |||
Magnesium Fluoride | |||||
Magnesium Metrizoate | |||||
Mandragora Autumnalis | |||||
Mannomustine Hydrochloride | |||||
Maprotiline Hydrochloride | |||||
Mebanazine | |||||
Mebendazole | For oral use in the treatment of enterobiasis in adults and in children not less than 2 years | 100mg (MD) | Container or package containing not more than 800mg of Mebendazole | ||
Mebeverine Hydrochloride | [F52(a) For the symptomatic relief of irritable bowel syndrome | [F52(a) 135 mg (MD) 405 mg (MDD)] | |||
(b) For uses other than the symptomatic relief of irritable bowel syndrome] | [F52(b) 100 mg (MD) 300 mg (MDD)] | ||||
Mebeverine Pamoate | |||||
Mebhydrolin | |||||
Mebhydrolin Napadisylate | |||||
Mecamylamine Hydrochloride | |||||
Mecillinam | |||||
Meclofenoxate Hydrochloride | |||||
Medigoxin | |||||
Medrogestone | |||||
Medroxyprogesterone Acetate | |||||
Mefenamic Acid | |||||
Mefloquine Hydrochloride | |||||
Mefruside | |||||
Megestrol | |||||
Megestrol Acetate | |||||
Meglumine Gadopentetate | |||||
Meglumine Iodoxamate | |||||
Meglumine Ioglycamate | |||||
Meglumine Iothalamate | |||||
Meglumine Iotroxate | |||||
Meglumine Ioxaglate | |||||
[F16Meloxicam] | |||||
Melphalan | |||||
Melphalan Hydrochloride | |||||
Menotrophin | |||||
Mepenzolate Bromide | 25mg (MD) | ||||
75mg (MDD) | |||||
Mephenesin | |||||
Mephenesin Carbamate | |||||
Mepivacaine Hydrochloride | Any use except ophthalmic use | ||||
Meptazinol Hydrochloride | |||||
Mequitazine | |||||
[F5Mercaptamine Bitartrate] | |||||
Mercaptopurine | |||||
Mersalyl | |||||
Mersalyl Acid | |||||
Mesalazine | |||||
Mesna | |||||
Mestranol | |||||
Metaraminol Tartrate | |||||
Metergoline | |||||
Metformin Hydrochloride | |||||
Methacycline | |||||
Methacycline Calcium | |||||
Methacycline Hydrochloride | |||||
Methallenoestril | |||||
Methicillin Sodium | |||||
Methixene | |||||
Methixene Hydrochloride | |||||
Methocarbamol | |||||
Methocidin | Throat lozenges and throat pastilles | ||||
Methohexitone Sodium | |||||
Methoin | |||||
Methoserpidine | |||||
Methotrexate | |||||
Methotrexate Sodium | |||||
Methotrimeprazine | |||||
Methotrimeprazine Hydrochloride | |||||
Methotrimeprazine Maleate | |||||
Methoxamine Hydrochloride | 0.25 per cent | Nasal sprays or nasal drops not containing liquid paraffin as a vehicle | |||
Methsuximide | |||||
Methyclothiazide | |||||
Methyldopa | |||||
Methyldopate Hydrochloride | |||||
Methylephedrine Hydrochloride | 30mg (MD) | ||||
60mg (MDD) | |||||
Methylprednisolone | |||||
Methylprednisolone Acetate | |||||
Methylprednisolone Sodium Succinate | |||||
Methylthiouracil | |||||
Methysergide Maleate | |||||
Metipranolol | |||||
Metirosine | |||||
Metoclopramide Hydrochloride | |||||
Metolazone | |||||
Metoprolol Fumarate | |||||
Metoprolol Succinate | |||||
Metoprolol Tartrate | |||||
Metronidazole | |||||
Metronidazole Benzoate | |||||
Metyrapone | |||||
Mexiletine Hydrochloride | |||||
Mezlocillin Sodium | |||||
Mianserin Hydrochloride | |||||
Miconazole | External but in the case of vaginal use only external use for the treatment of vaginal candidiasis | ||||
Miconazole Nitrate | External but in the case of vaginal use only external use for the treatment of vaginal candidiasis | ||||
Mifepristone | |||||
Miglitol | |||||
Milrinone | |||||
Milrinone Lactate | |||||
Minocycline | |||||
Minocycline Hydrochloride | |||||
Minoxidil | [F53(1) 2.0 per cent] | [F53(1) External | |||
[F53(2) 5.0 per cent | (2) External use for the treatment of alopecia androgenetica, in men aged 18 to 65 (but not in women);] | ||||
[F1Mirtazapine] | |||||
Misoprostol | |||||
Mitobronitol | |||||
Mitomycin | |||||
Mitozantrone Hydrochloride | |||||
Mivacurium Chloride | |||||
[F26Mizolastine] | |||||
Moclobemide | |||||
[F5Modafinil] | |||||
[F2Moexipril Hydrochloride] | |||||
Molgramostim | |||||
Molindone Hydrochloride | |||||
Mometasone Furoate | |||||
Moracizine Hydrochloride | |||||
Morazone Hydrochloride | |||||
[F1Moxonidine] | |||||
Mupirocin | |||||
Mupirocin Calcium | |||||
Mustine Hydrochloride | |||||
Nabilone | |||||
Nabumetone | |||||
Nadolol | |||||
Nafarelin Acetate | |||||
Naftidrofuryl Oxalate | |||||
Naftifine Hydrochloride | |||||
Nalbuphine Hydrochloride | |||||
Nalidixic Acid | |||||
Nalorphine Hydrobromide | |||||
Naloxone Hydrochloride | |||||
Naltrexone Hydrochloride | |||||
Naphazoline Hydrochloride | (1) 0.05 per cent | (1) Nasal sprays or nasal drops not containing liquid paraffin as a vehicle | |||
(2) 0.015 per cent | (2) Eye drops | ||||
Naphazoline Nitrate | 0.05 per cent | Nasal sprays or nasal drops not containing liquid paraffin as a vehicle | |||
Naproxen | |||||
Naproxen Sodium | |||||
[F5Naratriptan Hydrochloride] | |||||
Natamycin | |||||
[F17Nebivolol Hydrochloride] | |||||
Nedocromil Sodium | [F542.0 per cent] | [F54For the prevention, relief and treatment of seasonal and perennial allergic conjunctivitis] | [F54Container or package containing not more than 3 ml of medicinal product] | ||
Nefazodone Hydrochloride | |||||
Nefopam Hydrochloride | |||||
Neomycin | |||||
Neomycin Oleate | |||||
Neomycin Palmitate | |||||
Neomycin Sulphate | |||||
Neomycin Undecanoate | |||||
Neostigmine Bromide | |||||
Neostigmine Methylsulphate | |||||
Netilmicin Sulphate | |||||
Nicardipine Hydrochloride | |||||
Nicergoline | |||||
[F26Niceritrol] | |||||
Nicotinic Acid | Any use, except for the treatment of hyperlipidaemia | 600mg (MDD) | |||
Nicoumalone | |||||
Nifedipine | |||||
Nifenazone | |||||
Nikethamide | |||||
[F4Nilutamide] | |||||
Nimodipine | |||||
Niridazole | |||||
[F17Nisoldipine] | |||||
Nitrendipine | |||||
Nitrofurantoin | |||||
Nitrofurazone | |||||
Nizatidine | For the prevention [F55and treatment] of the symptoms of food-related heartburn [F55and meal-induced indigestion] | 75mg (MD) | |||
[F56150mg (MDD)] | |||||
[F57For a maximum period of 14 days] | |||||
For use in adults and children not less than 16 years | |||||
Nomifensine Maleate | |||||
Noradrenaline | |||||
Noradrenaline Acid Tartrate | |||||
Norethisterone | |||||
Norethisterone Acetate | |||||
Norethisterone Enanthate | |||||
Norethynodrel | |||||
Norfloxacin | |||||
Norgestimate | |||||
Norgestrel | |||||
Nortriptyline Hydrochloride | |||||
Noscapine | |||||
Noscapine Hydrochloride | |||||
Novobiocin Calcium | |||||
Novobiocin Sodium | |||||
Nux Vomica Seed | |||||
Nystatin | [F583.0 per cent] | [F58External | [F58Container or package containing not more than 15g of medicinal product] | ||
For use in combination with Hydrocortisone of maximum strength 0.5 per cent for intertrigo | |||||
For use in adults and children not less than 10 years] | |||||
Octacosactrin | |||||
Octreotide | |||||
Oestradiol | |||||
Oestradiol Benzoate | |||||
Oestradiol Cypionate | |||||
Oestradiol Dipropionate | |||||
Oestradiol Diundecanoate | |||||
Oestradiol Enanthate | |||||
Oestradiol Phenylpropionate | |||||
Oestradiol Undecanoate | |||||
Oestradiol Valerate | |||||
Oestriol | |||||
Oestriol Succinate | |||||
Oestrogenic Substances Conjugated | |||||
Oestrone | |||||
Ofloxacin | |||||
Olsalazine Sodium | |||||
Omeprazole | |||||
[F1Omeprazole Magnesium] | |||||
Ondansetron Hydrochloride | |||||
Orciprenaline Sulphate | |||||
Orphenadrine Citrate | |||||
Orphenadrine Hydrochloride | |||||
Ouabain | |||||
Ovarian Gland Dried | |||||
Oxamniquine | |||||
Oxantel Embonate | |||||
Oxaprozin | |||||
Oxatomide | |||||
Oxedrine Tartrate | |||||
Oxethazaine | 10mg (MD) | Container or package containing not more than 400mg of Oxethazaine | |||
30mg (MDD) | |||||
Oxitropium Bromide | |||||
Oxolinic Acid | |||||
Oxpentifylline | |||||
Oxprenolol Hydrochloride | |||||
Oxybuprocaine Hydrochloride | Non-ophthalmic use | ||||
Oxybutynin Hydrochloride | |||||
Oxypertine | |||||
Oxypertine Hydrochloride | |||||
Oxyphenbutazone | |||||
Oxyphencyclimine Hydrochloride | |||||
Oxyphenonium Bromide | 5mg (MD) | ||||
15mg (MDD) | |||||
Oxytetracycline | |||||
Oxytetracycline Calcium | |||||
Oxytetracycline Dihydrate | |||||
Oxytetracycline Hydrochloride | |||||
Oxytocin, natural | |||||
Oxytocin, synthetic | |||||
Pancreatin | (1) 21,000 European Pharmacopoeia units of lipase per capsule | (1) capsules | |||
(2) 25,000 European Pharmacopoeia units of lipase per gram | (2) powder | ||||
Pancuronium Bromide | |||||
[F16Pantoprazole Sodium] | |||||
Papaverine | (1) By inhaler | ||||
(2) Otherwise than by inhaler | (2) 50mg (MD) | ||||
150mg (MDD) | |||||
Papaverine Hydrochloride | (1) By inhaler | ||||
(2) Otherwise than by inhaler | (2) Equivalent of 50mg of Papaverine (MD) | ||||
Equivalent of 150mg of Papaverine (MDD) | |||||
[F6Paracetamol | (1) [F59250mg] | (1) Non-effervescent tablets and capsules [F60wholly or mainly] for use in children aged less than 12 years | (1) The quantity sold or supplied in one container or package shall not exceed 32
| ||
(2) 500 mg | (2) Non-effervescent tablets and capsules [F61wholly or mainly] for use in adults and children not less than 12 years | ||||
(3) All preparations other than non-effervescent tablets and capsules | (2) The quantity sold or supplied in one container or package shall not exceed 32
| ||||
Paraldehyde | |||||
Paramethadione | |||||
Paramethasone Acetate | |||||
Parathyroid Gland | |||||
Pargyline Hydrochloride | |||||
Paroxetine Hydrochloride | |||||
Pecilocin | |||||
Penamecillin | |||||
Penbutolol Sulphate | |||||
[F16Penciclovir] | |||||
Penicillamine | |||||
Penicillamine Hydrochloride | |||||
Pentamidine Isethionate | |||||
Penthienate Bromide | 5mg (MD) | ||||
15mg (MDD) | |||||
Pentolinium Tartrate | |||||
Perfluamine | |||||
Pergolide Mesylate | |||||
Perhexiline Maleate | |||||
Pericyazine | |||||
Perindopril | |||||
Perindopril Erbumine | |||||
Perphenazine | |||||
Phenacetin | 0.1 per cent | ||||
Phenazone | External | ||||
Phenazone Salicylate | |||||
Phenbutrazate Hydrochloride | |||||
Phenelzine Sulphate | |||||
Phenethicillin Potassium | |||||
Phenformin Hydrochloride | |||||
Phenglutarimide Hydrochloride | |||||
Phenindione | |||||
[F62Phenolphthalein.] | |||||
Phenoxybenzamine Hydrochloride | |||||
Phenoxymethylpenicillin | |||||
Phenoxymethylpenicillin Calcium | |||||
Phenoxymethylpenicillin Potassium | |||||
Phenprocoumon | |||||
Phensuximide | |||||
Phentolamine Hydrochloride | |||||
Phentolamine Mesylate | |||||
Phenylbutazone | |||||
Phenylbutazone Sodium | |||||
Phenylpropanolamine Hydrochloride | Internal | ||||
(1) all preparations except prolonged release capsules, nasal sprays and nasal drops | (1) 25mg (MD) | ||||
100mg (MDD) | |||||
(2) prolonged release capsules | (2) 50mg (MD) | ||||
100mg (MDD) | |||||
(3) 2.0 per cent | (3) nasal sprays and nasal drops | ||||
Phenytoin | |||||
Phenytoin Sodium | |||||
Phthalylsulphathiazole | |||||
Physostigmine | |||||
Physostigmine Aminoxide Salicylate | |||||
Physostigmine Salicylate | |||||
Physostigmine Sulphate | |||||
[F4Phytomenadione | Any use except the prevention or treatment of haemorrhagic disorders] | ||||
Picrotoxin | |||||
Pilocarpine | |||||
Pilocarpine Hydrochloride | |||||
Pilocarpine Nitrate | |||||
Pimozide | |||||
Pindolol | |||||
Pipenzolate Bromide | 5mg (MD) | ||||
15mg (MDD) | |||||
Piperacillin Sodium | |||||
Piperazine Oestrone Sulphate | |||||
Piperidolate Hydrochloride | 50mg (MD) | ||||
150mg (MDD) | |||||
Pipothiazine Palmitate | |||||
Piracetam | |||||
Pirbuterol Acetate | |||||
Pirbuterol Hydrochloride | |||||
[F63Pirenzepine Dihydrochloride Monohydrate] | |||||
Pirenzepine Hydrochloride | |||||
Piretanide | |||||
Piroxicam | 0.5 per cent | External | For maximum period of 7 days | Container or package containing not more than 30g of medicinal product | |
For the relief of rheumatic pain, pain of non-serious arthritic conditions and muscular aches, pains and swellings such as strains, sprains and sports injuries | |||||
For use in adults and children not less than 12 years | |||||
[F26Piroxicam Beta-cyclodextrin] | |||||
Pituitary Gland (Whole Dried) | By inhaler | ||||
Pituitary Powdered (Posterior Lobe) | By inhaler | ||||
Pivampicillin | |||||
Pivampicillin Hydrochloride | |||||
Pivmecillinam | |||||
Pivmecillinam Hydrochloride | |||||
Pizotifen | |||||
Pizotifen Malate | |||||
Plicamycin | |||||
Podophyllotoxin | |||||
Podophyllum | |||||
Podophyllum Indian | |||||
Podophyllum Resin | 20.0 per cent | External | |||
Ointment or impregnated plaster | |||||
Poldine Methylsulphate | 2mg (MD) | ||||
6mg (MDD) | |||||
Polidexide | |||||
Polyestradiol Phosphate | |||||
Polymyxin B Sulphate | |||||
Polythiazide | |||||
Poppy Capsule | |||||
Potassium Arsenite | 0.0127 per cent | ||||
Potassium Bromide | |||||
Potassium Canrenoate | |||||
Potassium Clavulanate | |||||
Potassium Perchlorate | |||||
Practolol | |||||
Pralidoxime Chloride | |||||
Pralidoxime Iodide | |||||
Pralidoxime Mesylate | |||||
[F5Pramipexole Hydrochloride] | |||||
Pravastatin Sodium | |||||
Prazosin Hydrochloride | |||||
Prednisolone | |||||
Prednisolone Acetate | |||||
Prednisolone Butylacetate | |||||
Prednisolone Hexanoate | |||||
Prednisolone Metasulphobenzoate | |||||
Prednisolone Metasulphobenzoate Sodium | |||||
Prednisolone Pivalate | |||||
Prednisolone Sodium Phosphate | |||||
Prednisolone Steaglate | |||||
Prednisone | |||||
Prednisone Acetate | |||||
Prenalterol Hydrochloride | |||||
Prenylamine Lactate | |||||
Prilocaine Hydrochloride | Non-ophthalmic use | ||||
Primidone | |||||
Probenecid | |||||
Probucol | |||||
Procainamide Hydrochloride | |||||
Procaine Hydrochloride | Non-ophthalmic use | ||||
Procaine Penicillin | |||||
Procarbazine Hydrochloride | |||||
Prochlorperazine | |||||
Prochlorperazine Edisylate | |||||
Prochlorperazine Maleate | [F203mg] | [F20Buccal tablets for the treatment of nausea and vomiting in cases of previously diagnosed migraine only. For use in persons aged 18 years and over.] | [F2012mg (MDD)] | [F20Container or package containing not more than 8 tablets] | |
Prochlorperazine Mesylate | |||||
Procyclidine Hydrochloride | |||||
Progesterone | |||||
Prolactin | |||||
Proligestone | |||||
Prolintane Hydrochloride | |||||
Promazine Embonate | |||||
Promazine Hydrochloride | |||||
Propafenone | |||||
Propafenone Hydrochloride | |||||
Propanidid | |||||
Propantheline Bromide | 15mg (MD) | ||||
45mg (MDD) | |||||
[F17Propiverine Hydrochloride] | |||||
Propofol | |||||
Propranolol Hydrochloride | |||||
Propylthiouracil | |||||
Proquazone | |||||
Protamine Sulphate | |||||
Prothionamide | |||||
Protirelin | |||||
Protriptyline Hydrochloride | |||||
Proxymetacaine Hydrochloride | Non-ophthalmic use | ||||
Pseudoephedrine Hydrochloride | Internal | (a) In the case of a prolonged release preparation | |||
120mg (MD) | |||||
240mg (MDD) | |||||
(b) in any other case 60mg (MD) | |||||
240mg (MDD) | |||||
Pseudoephedrine Sulphate | 60mg (MD) | ||||
180mg (MDD) | |||||
Pyrantel Embonate | (a) For the treatment of enterobiosis, in adults and children not less than 12 years | (a) 750mg MDD (as a single dose) | (a) Container or package containing not more than 750mg of Pyrantel Embonate | ||
(b) For the treatment of enterobiosis, in children less than 12 years but not less than 6 years | (b) 500mg MDD (as a single dose) | (b) Container or package containing not more than 750mg of Pyrantel Embonate | |||
(c) For the treatment of enterobiosis in children less than 6 years but not less than 2 years | (c) 250mg MDD (as a single dose) | (c) Container or package containing not more than 750mg of Pyrantel Embonate | |||
Pyrantel Tartrate | |||||
Pyrazinamide | |||||
Pyridostigmine Bromide | |||||
Pyrimethamine | |||||
[F17Quetiapine Fumarate] | |||||
[F2Quinagolide Hydrochloride] | |||||
Quinapril | |||||
[F63Quinapril Hydrochloride] | |||||
Quinestradol | |||||
Quinestrol | |||||
Quinethazone | |||||
Quinidine | |||||
Quinidine Bisulphate | |||||
Quinidine Polygalacturonate | |||||
Quinidine Sulphate | |||||
Quinine | 100mg (MD) | ||||
300mg (MDD) | |||||
Quinine Bisulphate | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Cinchophen | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Dihydrochloride | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Ethyl Carbonate | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Glycerophosphate | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Hydrobromide | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Hydrochloride | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Iodobismuthate | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Phosphate | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Salicylate | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Sulphate | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine Tannate | Equivalent of 100mg of Quinine (MD) | ||||
Equivalent of 300mg of Quinine (MDD) | |||||
Quinine in combination with Urea Hydrochloride | |||||
Ramipril | |||||
[F1Ranitidine Bismuth Citrate] | |||||
Ranitidine Hydrochloride | For the short term symptomatic relief of heartburn, dyspepsia, indigestion, acid indigestion and hyperacidity [F64or the prevention of these symptoms when associated with consuming food and drink] | Equivalent to 75mg of Ranitidine (MD) | |||
Equivalent to 300mg of Ranitidine (MDD) | |||||
For a maximum period of 14 days | |||||
Rauwolfia Serpentina | |||||
Rauwolfia Vomitoria | |||||
Razoxane | |||||
[F5Reboxetine Mesilate] | |||||
Remoxipride Hydrochloride | |||||
Reproterol Hydrochloride | |||||
Rescinnamine | |||||
Reserpine | |||||
Rifabutin | |||||
Rifampicin | |||||
Rifampicin Sodium | |||||
Rifamycin | |||||
[F1Rimexolone] | |||||
Rimiterol Hydrobromide | |||||
Risperidone | |||||
Ritodrine Hydrochloride | |||||
Rolitetracycline Nitrate | |||||
[F21Ropinirole Hydrochloride] | |||||
Sabadilla | |||||
Salbutamol | |||||
Salbutamol Sulphate | |||||
Salcatonin | |||||
Salcatonin Acetate | |||||
Salmefamol | |||||
Salmeterol Xinafoate | |||||
Salsalate | |||||
Saralasin Acetate | |||||
Selegiline Hydrochloride | |||||
Semisodium Valproate | |||||
[F5Sertindole] | |||||
[F1Sertraline Hydrochloride] | |||||
Serum Gonadotrophin | |||||
[F1Sevoflurane] | |||||
Silver Sulphadiazine | |||||
Simvastatin | |||||
Sissomicin | |||||
Sissomicin Sulphate | |||||
Snake Venoms | |||||
Sodium Acetrizoate | |||||
Sodium Aminosalicylate | |||||
Sodium Antimonylgluconate | |||||
Sodium Arsanilate | |||||
Sodium Arsenate | |||||
Sodium Arsenite | 0.013 per cent | ||||
Sodium Bromide | |||||
Sodium Clodronate | |||||
Sodium Cromoglycate | (a) For nasal admistration | ||||
(b) 2.0 per cent | (b) For the treatment of acute seasonal allergic conjunctivitis [F65or perennial allergic conjunctivitis] | (b) Container or package containing not more than 10ml of medicinal product | |||
In the form of aqueous eye drops | |||||
(c) 4.0 per cent | (c) For the treatment of acute seasonal allergic conjunctivitis | (c) Container or package containing not more than 5g of medicinal product | |||
In the form of an eye ointment | |||||
Sodium Ethacrynate | |||||
Sodium Fluoride | (1) 0.33 per cent | (1) Dentifrices | |||
(2) Other preparations for use in the prevention of dental caries | |||||
In the form of | |||||
(a) tablets or drops | (a) 2.2 mg (MDD) | ||||
(b) 0.2 per cent | (b) mouth rinses other than those for daily use | ||||
(c) 0.05 per cent | (c) mouth rinses for daily use | ||||
Sodium Fusidate | |||||
Sodium Metrizoate | |||||
Sodium Monofluorophosphate | 1.14 per cent | Dentrifrice | |||
Sodium Oxidronate | |||||
Sodium Stibogluconate | |||||
Sodium Valproate | |||||
Somatorelin Acetate | |||||
Sotalol Hydrochloride | |||||
[F2Sparfloxacin] | |||||
Spectinomycin | |||||
Spectinomycin Hydrochloride | |||||
Spiramycin | |||||
Spiramycin Adipate | |||||
Spironolactone | |||||
Stannous Fluoride | ([F661]) 0.62 per cent | ([F661]) Dentifrice | |||
[F66(2) 0.4 per] | [F66(2) Dental gels for use in the prevention and treatment of dental caries and decalcification of the teeth] | ||||
Stilboestrol | |||||
Stilboestrol Dipropionate | |||||
Streptodornase | External | ||||
Streptokinase | External | ||||
Streptomycin | |||||
Streptomycin Sulphate | |||||
Strychnine | |||||
Strychnine Arsenate | |||||
Strychnine Hydrochloride | |||||
[F4Strychnine Nitrate] | |||||
Styramate | |||||
Succinylsulphathiazole | |||||
Sucralfate | |||||
Sulbactam Sodium | |||||
Sulbenicillin | |||||
Sulbenicillin Sodium | |||||
Sulconazole Nitrate | External (except vaginal) | ||||
[F4Sulfabenzamide] | |||||
Sulfacytine | |||||
Sulfadoxine | |||||
Sulfamerazine | |||||
Sulfamerazine Sodium | |||||
Sulfametopyrazine | |||||
Sulfamonomethoxine | |||||
Sulindac | |||||
Sulphacetamide | |||||
Sulphacetamide Sodium | |||||
Sulphadiazine | |||||
Sulphadiazine Sodium | |||||
Sulphadimethoxine | |||||
Sulphadimidine | |||||
Sulphadimidine Sodium | |||||
Sulphafurazole | |||||
Sulphafurazole Diethanolamine | |||||
Sulphaguanidine | |||||
Sulphaloxic Acid | |||||
Sulphamethizole | |||||
Sulphamethoxazole | |||||
Sulphamethoxydiazine | |||||
Sulphamethoxypyridazine | |||||
Sulphamethoxypyridazine Sodium | |||||
Sulphamoxole | |||||
Sulphanilamide | |||||
Sulphaphenazole | |||||
Sulphapyridine | |||||
Sulphapyridine Sodium | |||||
Sulphasalazine | |||||
Sulphathiazole | |||||
Sulphathiazole Sodium | |||||
Sulphaurea | |||||
Sulphinpyrazone | |||||
Sulpiride | |||||
Sultamicillin | |||||
Sultamicillin Tosylate | |||||
Sulthiame | |||||
Sumatriptan Succinate | |||||
Suprofen | |||||
Suxamethonium Bromide | |||||
Suxamethonium Chloride | |||||
Suxethonium Bromide | |||||
[F17Tacalcitol Monohydrate] | |||||
Tacrine Hydrochloride | |||||
Talampicillin | |||||
Talampicillin Hydrochloride | |||||
Talampicillin Napsylate | |||||
Tamoxifen | |||||
Tamoxifen Citrate | |||||
[F16Tamsulosin Hydrochloride] | |||||
[F1Tazarotene] | |||||
Tazobactam Sodium | |||||
Teicoplanin | |||||
[F5Temocapril Hydrochloride] | |||||
Temocillin Sodium | |||||
Tenoxicam | |||||
Terazosin Hydrochloride | |||||
Terbinafine | [F671.0 per cent] | [F68External use for the treatment of tinea pedis, tinea cruris and tinea corporis. In the form of a gel] | [F69Container or package containing not more than 30 grams of medicinal product] | ||
[F70Terbinafine Hydrochloride] | [F701.0 per cent] | ([F711]) [F72Preparations, other than spray solutions, for] [F70external use for the treatment of tinea pedis and tinea cruris] | ([F711]) [F70Container or package containing not more than 15 g of medicinal product.] | ||
[F73(2) Spray solutions for external use for the treatment of tinea corporis, tinea cruris and tinea pedis] | [F73(2) Container containing not more than 30ml of medicinal product] | ||||
Terbutaline | |||||
Terbutaline Sulphate | |||||
Terfenadine | F74. . . | F74... | |||
Terlipressin | |||||
Terodiline Hydrochloride | |||||
[F5Testosterone] | |||||
Tetrabenazine | |||||
Tetracosactrin | |||||
Tetracosactrin Acetate | |||||
Tetracycline | |||||
Tetracycline Hydrochloride | |||||
Tetracycline Phosphate Complex | |||||
Tetroxoprim | |||||
Thallium Acetate | |||||
Thallous Chloride | |||||
Thiabendazole | |||||
Thiambutosine | |||||
Thiethylperazine Malate | |||||
Thiethylperazine Maleate | |||||
Thiocarlide | |||||
Thioguanine | |||||
Thiopentone Sodium | |||||
Thiopropazate Hydrochloride | |||||
Thioproperazine Mesylate | |||||
Thioridazine | |||||
Thioridazine Hydrochloride | |||||
Thiosinamine | |||||
Thiotepa | |||||
Thiothixene | |||||
Thiouracil | |||||
Thymoxamine Hydrochloride | |||||
Thyroid | |||||
Thyrotrophin | |||||
Thyroxine Sodium | |||||
Tiamulin Fumarate | |||||
Tiaprofenic Acid | |||||
Tibolone | |||||
Ticarcillin Sodium | |||||
[F16Ticlopidine Hydrochloride] | |||||
Tigloidine Hydrobromide | |||||
[F16Tiludronate Disodium] | |||||
Timolol Maleate | |||||
Tinidazole | |||||
Tinzaparin | |||||
Tioconazole | (1) 2.0 per cent | (1) External (except vaginal) | |||
(2) Vaginal for treatment of vaginal candidiasis | |||||
[F2Tizanidine Hydrochloride] | |||||
Tobramycin | |||||
Tobramycin Sulphate | |||||
Tocainide Hydrochloride | |||||
Tofenacin Hydrochloride | |||||
Tolazamide | |||||
Tolazoline Hydrochloride | External | ||||
Tolbutamide | |||||
Tolbutamide Sodium | |||||
Tolfenamic Acid | |||||
Tolmetin Sodium | |||||
[F1Topiramate] | |||||
[F26Torasemide] | |||||
[F16Toremifene] | |||||
Tramadol Hydrochloride | |||||
Trandolapril | |||||
Tranexamic Acid | |||||
Tranylcypromine Sulphate | |||||
Trazodone Hydrochloride | |||||
Treosulfan | |||||
Tretinoin | |||||
Triamcinolone | |||||
Triamcinolone Acetonide | [F75(1)] 0.1 per cent | [F75(1)] For the treatment of common mouth ulcers | [F75(1)] Container or package containing not more than 5g of medicinal product | ||
[F76(2) In the form of a non-pressurised nasal spray, for the treatment of symptoms of seasonal allergic rhinitis in persons aged 18 years and over] | [F76(2) 110mcg per nostril (MD) | [F76Container or package containing not more than 3.575mg of Triamcinolone Acetonide] | |||
110mcg per nostril (MDD) | |||||
For a maximum period of 3 months] | |||||
Triamcinolone Diacetate | |||||
Triamcinolone Hexacetonide | |||||
Triamterene | |||||
Tribavirin | |||||
Triclofos Sodium | |||||
Trientine Dihydrochloride | |||||
Trifluoperazine | |||||
Trifluoperazine Hydrochloride | |||||
Trifluperidol | |||||
Trifluperidol Hydrochloride | |||||
Trilostane | |||||
Trimeprazine | |||||
Trimeprazine Tartrate | |||||
Trimetaphan Camsylate | |||||
Trimetazidine | |||||
Trimetazidine Hydrochloride | |||||
Trimethoprim | |||||
Trimipramine Maleate | |||||
Trimipramine Mesylate | |||||
Tropicamide | |||||
Tropisetron Hydrochloride | |||||
Troxidone | |||||
L-Tryptophan | (1) Oral | ||||
Dietary supplementation | |||||
(2) External | |||||
Tubocurarine Chloride | |||||
Tulobuterol | |||||
Tulobuterol Hydrochloride | |||||
Tyrothricin | Throat lozenges or throat pastilles | ||||
Uramustine | |||||
Urea Stibamine | |||||
Urethane | |||||
Uridine 5'-triphosphate | |||||
Urofollitrophin | |||||
Urokinase | |||||
Ursodeoxychoic Acid | |||||
Vaccine: Bacillus Salmonella Typhi | |||||
Vaccine: Poliomyelitis (Oral) | |||||
[F2Valaciclovir Hydrochloride] | |||||
Valproic Acid | |||||
[F5Valsartan] | |||||
Vancomycin Hydrochloride | |||||
Vasopressin | |||||
Vasopressin Tannate | |||||
Vecuronium Bromide | |||||
[F2Venlafaxine Hydrochloride] | |||||
Verapamil Hydrochloride | |||||
Veratrine | |||||
Veratrum, Green | |||||
Veratrum, White | |||||
Vidarabine | |||||
Vigabatrin | |||||
Viloxazine Hydrochloride | |||||
Vinblastine Sulphate | |||||
Vincristine Sulphate | |||||
Vindesine Sulphate | |||||
Viomycin Pantothenate | |||||
Viomycin Sulphate | |||||
Vitamin A | (1) Internal | (1) 7,500iu (2,250mcg Retinol equivalent) (MDD) | |||
(2) External | |||||
Vitamin A Acetate | (1) Internal | (1) Equivalent to 7,500iu Vitamin A (2,250mcg Retinol equivalent) (MDD) | |||
(2) External | |||||
Vitamin A Palmitate | (1) Internal | (1) Equivalent to 7,500iu Vitamin A (2,250mcg Retinol equivalent) (MDD) | |||
(2) External | |||||
Warfarin | |||||
Warfarin Sodium | |||||
Xamoterol Fumarate | |||||
Xipamide | |||||
Yohimbine Hydrochloride | |||||
[F2Zalcitabine] | |||||
Zidovudine | |||||
Zimeldine Hydrochloride | |||||
Zolpidem Tartrate | |||||
Zomepirac Sodium | |||||
Zopiclone | |||||
Zuclopenthixol Acetate | |||||
Zuclopenthixol Decanoate | |||||
Zuclopenthixol Hydrochloride] |
Textual Amendments
F1Words in Sch. 1 inserted (9.8.2000) by The Prescription Only Medicines (Human Use) Amendment Order 2000 (S.I. 2000/1917), arts. 1(1), 3(c)
F2Words in Sch. 1 inserted (19.1.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1999 (S.I. 1999/3463), arts. 1(1), 2(c)
F3Words in Sch. 1 inserted (24.8.2001) by The Prescription Only Medicines (Human Use) Amendment Order 2001 (S.I. 2001/2777), arts. 1(1), 3(a)
F4Words in Sch. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), art. 1(1), Sch.
F5Sch. 1 entries inserted (24.8.2001) by The Prescription Only Medicines (Human Use) Amendment Order 2001 (S.I. 2001/2777), arts. 1(1), 3(g)
F6Words in Sch. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1997 (S.I. 1997/2044), art. 1(1), Sch. 1
F7Words in Sch. 1 inserted (22.4.1999) by The Prescription Only Medicines (Human Use) Amendment Order 1999 (S.I. 1999/1044), arts. 1(1), 2(a)
F8Words in Sch. 1 substituted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(a)
F9Sch. 1: entries renumbered (22.4.1999) by The Prescription Only Medicines (Human Use) Amendment Order 1999 (S.I. 1999/1044), arts. 1(1), 2(a)
F10Words in Sch. 1 omitted (16.9.1998) by virtue of The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(b)
F11Words in Sch. 1 inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(a)
F12Words in Sch. 1 substituted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(a)
F13Word in Sch. 1 substituted (22.4.1999) by The Prescription Only Medicines (Human Use) Amendment Order 1999 (S.I. 1999/1044), arts. 1(1), 2(b)
F14Words in Sch. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(c)(ii)
F15Words in Sch. 1 substituted (16.9.1998) by virtue ofThe Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(c)(i)
F16Words in Sch. 1 inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(h)
F17Words in Sch. 1 inserted (22.4.1999) by The Prescription Only Medicines (Human Use) Amendment Order 1999 (S.I. 1999/1044), arts. 1(1), 2(e)
F18Word in Sch. 1 substituted (16.9.1997) by The Prescription Only Medicines (Human Use) Amendment Order 1997 (S.I. 1997/2044), arts. 1(1), 2(a)
F19Words in Sch. 1 revoked (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(a)
F20Sch. 1 entries inserted (24.8.2001) by The Prescription Only Medicines (Human Use) Amendment Order 2001 (S.I. 2001/2777), arts. 1(1), 3(f)
F21Sch. 1 entries inserted (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(e)
F22Sch. 1 entries inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(b)
F23Words in Sch. 1 inserted (1.6.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1998 (S.I. 1998/1178), arts. 1(1), 2(a)
F24Words in Sch. 1 substituted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(d)
F25Words in Sch. 1 substituted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(c)
F26Words in Sch. 1 inserted (13.2.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1998 (S.I. 1998/108), arts. 1, 3(e)(i)
F27Word in Sch. 1 substituted (19.1.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1999 (S.I. 1999/3463), arts. 1(1), 2(a)
F28Words in Sch. 1 substituted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(e)
F29Words in Sch. 1 inserted (24.8.2001) by The Prescription Only Medicines (Human Use) Amendment Order 2001 (S.I. 2001/2777), arts. 1(1), 3(b)
F30Words in Sch. 1 substituted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(f)(i)
F31Words in Sch. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(f)(ii)
F32Words in Sch. 1 omitted (16.9.1998) by virtue of The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(f)(iii)
F33Words in Sch. 1 inserted (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(b)(i)
F34Words in Sch. 1 inserted (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(b)(ii)
F35Words in Sch. 1 inserted (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(b)(iii)
F36Words in Sch. 1 inserted (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(b)(iv)
F37Words in Sch. 1 inserted (22.4.1999) by The Prescription Only Medicines (Human Use) Amendment Order 1999 (S.I. 1999/1044), arts. 1(1), 2(c)
F38Sch. 1: entries renumbered (22.4.1999) by The Prescription Only Medicines (Human Use) Amendment Order 1999 (S.I. 1999/1044), arts. 1(1), 2(c)
F39Words in Sch. 1 inserted (13.2.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1998 (S.I. 1998/108), arts. 1, 3(a)
F40Words in Sch. 1 inserted (24.8.2001) by The Prescription Only Medicines (Human Use) Amendment Order 2001 (S.I. 2001/2777), arts. 1(1), 3(c)
F41Words in Sch. 1 inserted (9.8.2000) by The Prescription Only Medicines (Human Use) Amendment Order 2000 (S.I. 2000/1917), arts. 1(1), 3(a)
F42Words in Sch. 1 substituted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(d)
F43Word in Sch. 1 inserted (13.8.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1998 (S.I. 1998/108), arts. 1, 3(e)(ii)
F44Word in Sch. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(g)(ii)
F45Words in Sch. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(g)(i)
F46Words in Sch. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(g)(iii)
F47Words in Sch. 1 inserted (19.1.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1999 (S.I. 1999/3463), arts. 1(1), 2(b)
F48Sch. 1 entries inserted (1.1.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 2000 (S.I. 2000/3231), arts. 1(1), 2
F49Words in Sch. 1 inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(e)(i)
F50Words in Sch. 1 inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(e)(ii)
F51Words in Sch. 1 revoked (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(c)
F52Words in Sch. 1 substituted (13.2.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1998 (S.I. 1998/108), arts. 1, 3(b)
F53Words in Sch. 1 substituted (1.6.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1998 (S.I. 1998/1178), arts. 1(1), 2(b)
F54Words in Sch. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 3(h)
F55Words in Sch. 1 inserted (1.6.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1998 (S.I. 1998/1178), arts. 1(1), 2(c)(i)
F56Words in Sch. 1 inserted (1.6.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1998 (S.I. 1998/1178), arts. 1(1), 2(c)(ii)
F57Words in Sch. 1 substituted (1.6.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1998 (S.I. 1998/1178), arts. 1(1), 2(c)(iii)
F58Words in Sch. 1 inserted (22.4.1999) by The Prescription Only Medicines (Human Use) Amendment Order 1999 (S.I. 1999/1044), arts. 1(1), 2(d)
F59Words in Sch. 1 substituted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(f)(i)
F60Words in Sch. 1 inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(f)(ii)
F61Words in Sch. 1 inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(f)(iii)
F62Words in Sch. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1998 (S.I. 1998/1178), arts. 1(1), 2(d)(ii)
F63Words in Sch. 1 inserted (1.6.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1998 (S.I. 1998/1178), arts. 1(1), 2(d)(i)
F64Words in Sch. 1 added (13.2.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1998 (S.I. 1998/108), arts. 1, 3(c)
F65Words in Sch. 1 inserted (13.2.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1998 (S.I. 1998/108), arts. 1, 3(d)
F66Sch. 1: entries renumbered (24.8.2001) by The Prescription Only Medicines (Human Use) Amendment Order 2001 (S.I. 2001/2777), arts. 1(1), 3(d)
F67Words in Sch. 1 inserted (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(d)(i)
F68Words in Sch. 1 inserted (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(d)(ii)
F69Words in Sch. 1 inserted (31.12.2001) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2001 (S.I. 2001/3942), arts. 1(1), 2(d)(iii)
F70Words in Sch. 1 inserted (9.8.2000) by The Prescription Only Medicines (Human Use) Amendment Order 2000 (S.I. 2000/1917), arts. 1(1), 3(b)
F71Sch. 1: entries renumbered (24.8.2001) by The Prescription Only Medicines (Human Use) Amendment Order 2001 (S.I. 2001/2777), arts. 1(1), 3(e)
F72Words in Sch. 1 inserted (24.8.2001) by The Prescription Only Medicines (Human Use) Amendment Order 2001 (S.I. 2001/2777), arts. 1(1), 3(e)
F73Sch. 1 entries inserted (24.8.2001) by The Prescription Only Medicines (Human Use) Amendment Order 2001 (S.I. 2001/2777), arts. 1(1), 3(e)
F74Words in Sch. 1 omitted (16.9.1997) by virtue of The Prescription Only Medicines (Human Use) Amendment Order 1997 (S.I. 1997/2044), arts. 1(1), 2(b)
F75Sch. 1 entries re-numbered (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(g)
F76Sch. 1 entries inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 4(g)
Articles 6(1) and 10
Column 1 | Circumstances excluding medicinal products from the class of prescription only medicines | ||
---|---|---|---|
Column 2 | Column 3 | Column 4 | |
Substance | Maximum strength | Pharmaceutical Form | Maximum Dose |
Codeine and its salts | Equivalent of 1.5 per cent of codeine monohydrate | Equivalent of 20 mg of codeine monohydrate | |
Dihydrocodeine and its salts | Equivalent of 1.5 per cent of dihydrocodeine | Equivalent of 10 mg of dihydrocodeine | |
Ethylmorphine andits salts | Equivalent of 0.2 per cent of ethylmorphine | Equivalent of 7.5 mg of ethylmorphine | |
Morphine and its salts | (1) Equivalent of 0.02 per cent anhydrous morphine | (1) Liquid | (1) Equivalent of 3 mg of anhydrous morphine |
(2) Equivalent of 0.04 per cent of anhydrous morphine; equivalent of 300 mcg of anhydrous morphine | (2) Solid | (2) Equivalent of 3 mg of anhydrous morphine | |
Medicinal Opium | (1) Equivalent of 0.02 per cent of anhydrous morphine | (1) Liquid | (1) Equivalent of 3 mg of anhydrous morphine |
(2) Equivalent of 0.04 per cent of anhydrous morphine | (2) Solid | (2) Equivalent of 3 mg of anhydrous morphine | |
Pholcodine and its salts | Equivalent of 1.5 per cent of pholcodine monohydrate | Equivalent of 20 mg of pholcodine monohydrate |
Article 2(b)
[F77Co-danthramer Capsules NPF]
[F77Co-danthramer Capsules, Strong NPF]
Co-danthramer-Oral Suspension NPF
Co-danthramer-Oral Suspension Strong NPF
Co-danthrusate Capsules
[F77Co-danthrusate Oral Suspension NPF]
Mebendazole Tablets NPF
Mebendazole Oral Suspension NPF
Miconazole Oral Gel NPF
Nystatin Oral Suspension
Nystatin Pastilles NPF
Streptokinase and Streptodornase Topical Powder NPF
[F78Water for Injections]
Textual Amendments
F77Words in Sch. 3 inserted (13.2.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1998 (S.I. 1998/108), arts. 1, 4
F78Words in Sch. 3 inserted (4.4.2003) by The Prescription Only Medicines (Human Use) Amendment Order 2003 (S.I. 2003/696), arts. 1(1), 14
Article 3A
Textual Amendments
F79Sch. 3A inserted (1.4.2002) by The Prescription Only Medicines (Human Use) Amendment Order 2002 (S.I. 2002/549), arts. 1(1), 9
Column 1 | Column 2 |
---|---|
Substance | Requirements as to use, route of administration, or pharmaceutical form |
Aciclovir | External use |
Acrivastine | Oral |
Adapalene | External use |
Alclometasone dipropionate | External use |
Alimemazine tartrate (trimeprazine tartrate) | Oral |
[F80Amitriptyline hydrochloride | Oral] |
Amorolfine hydrochloride | External use |
Amoxycillin trihydrate | Oral |
Aspirin | Oral |
Azelaic acid | External use |
Azelastine hydrochloride | Ophthalmic use or nasal |
[F80Azithromycin dihydrate | Oral] |
Baclofen | Oral administration in palliative care |
Beclometasone dipropionate | External use or nasal |
Betamethasone dipropionate | External use |
Betamethasone sodium phosphate | Aural or nasal |
Betamethasone valerate | External use |
Budesonide | Nasal |
[F80Carbamazepine | Oral or rectal] |
Carbaryl | External use |
Carbenoxolone sodium | Mouthwash |
Cetirizine hydrochloride | Oral |
Chloramphenicol | Ophthalmic use |
Cimetidine | Oral |
Cinchocaine hydrochloride | External use |
[F80Clavulanic acid | Oral] |
Clindamycin phosphate | External use |
Clobetasone butyrate | External use |
Clotrimazole | External use |
[F81Codeine Phosphate | Oral] |
[F80Conjugated oestrogens (equine) | External use] |
[F81Co-Phenotrope | Oral] |
Cyclizine | Parenteral administration in palliative care |
Dantrolene sodium | Oral administration in palliative care |
Dantron | Oral |
Desogestrel | Oral |
Desoximetasone (Desoxymethasone) | External use |
Dexamethasone | Aural |
Dexamethasone isonicotinate | Nasal |
[F81Diazepam | Oral, parenteral or rectal administration in palliative care] |
Diclofenac diethylammonium | External use |
[F80Diclofenac potassium | Oral] |
[F80Diclofenac sodium | Oral or rectal] |
[F81Dihydrocodeine Tartrate | Oral] |
Domperidone | Oral or rectal administration in palliative care |
Domperidone maleate | Oral administration in palliative care |
Doxycycline [F82hyclate] | Oral |
[F83Doxycycline monohydrate | Oral] |
Econazole nitrate | External use |
[F83Emedastine | Ophthalmic use] |
Erythromycin | External use [F84or oral] |
[F80Erythromycin ethyl succinate | Oral] |
[F80Erythromycin stearate | Oral] |
[F80Estradiol | External use] |
[F80Estriol | External use] |
Ethinylestradiol | Oral |
[F80Etonogestrel | Implant] |
Etynodiol diacetate (ethynodiol diacetate) | Oral |
Famotidine | Oral |
Felbinac | External use |
Fenticonazole nitrate | External use |
Fexofenadine hydrochloride | Oral |
[F83Flucloxacillin magnesium | Oral] |
Flucloxacillin sodium | Oral |
Fluconazole | Oral |
Fludroxycortide (Flurandrenolone) | External use |
[F80Flumazenil | Parenteral] |
Flumetasone pivalate | Aural |
Flunisolide | Nasal |
Fluocinolone acetonide | External use |
Fluocinonide | External use |
Fluocortolone hexanoate | External use |
Fluocortolone pivalate | External use |
Flurbiprofen | Lozenges |
Fluticasone propionate | External use or nasal |
Fusidic acid | [F85External Use] |
[F80Gabapentin | Oral] |
Gentamicin sulphate | Aural |
Gestodene | Oral |
[F80Glucagon hydrochloride | Parenteral] |
[F80Glucose | Parenteral] |
Hydrocortisone | External use |
Hydrocortisone acetate | External use |
Hydrocortisone butyrate | External use |
Hydrocortisone sodium succinate | Lozenges |
Hyoscine butylbromide | Parenteral [F86or transdermal] administration in palliative care |
Hyoscine hydrobromide | [F87Oral or parenteral administration in palliative care] |
Ibuprofen | External use or oral |
Ibuprofen lysine | Oral |
[F80Imipramine hydrochloride | Oral] |
Ipratropium bromide | Nasal |
Isotretinoin | External use |
Ketoconazole | External use |
Ketoprofen | External use |
Levocabastine hydrochloride | Ophthalmic use or nasal |
Levomepromazine (methotrimeprazine) maleate | Oral administration in palliative care |
Levomepromazine (methotrimeprazine) hydrochloride | Parenteral administration in palliative care |
Levonorgestrel | Oral |
[F80Lignocaine hydrochloride | External use or parenteral] |
Lithium succinate | External use |
Lodoxamide trometamol | Ophthalmic use |
Loperamide hydrochloride | Oral |
Loratadine | Oral |
[F81Lorazepam | Oral or parenteral administration in palliative care] |
[F80Lymecycline | Oral] |
Mebendazole | Oral |
Medroxyprogesterone acetate | Parenteral |
Mestranol | Oral |
Metoclopramide hydrochloride | Oral or parenteral administration in palliative care |
Metronidazole | [F88External use, oral or rectal] |
Metronidazole benzoate | Oral |
Miconazole | Dental lacquer |
Miconazole nitrate | External use |
[F81Midazolam | Parenteral administration in palliative care] |
Minocycline | Oral |
[F83Mizolastine | Oral] |
[F83Minocycline hydrochloride | Oral |
Mometasone furoate | External use or nasal |
Nedocromil sodium | Ophthalmic use |
Nefopam hydrochloride | Oral |
Neomycin sulphate | Aural |
Neomycin undecenoate | Aural |
Nitrofurantoin | Oral |
Nizatidine | Oral |
Norethisterone 9 | Oral |
Norethisterone acetate | Oral |
Norethisterone enanthate | Parenteral |
Norgestimate | Oral |
Norgestrel | Oral |
[F80Nortriptyline hydrochloride | Oral] |
Nystatin | External use |
Oxytetracycline dihydrate | Oral |
Paracetamol | Oral |
Penciclovir | External use |
Piroxicam | External use |
[F80Prednisolone | Oral] |
Prednisolone hexanoate | External use |
Prednisolone sodium phosphate | Aural [F89or oral] |
Ranitidine hydrochloride | Oral |
[F80Salbutamol sulphate | Inhalation] |
Silver sulphadiazine | External use |
Sodium cromoglycate | Ophthalmic use |
[F80Sodium fusidate | External use] |
Streptodornase | External use |
Streptokinase | External use |
Sulconazole nitrate | External use |
Terbinafine hydrochloride | External use |
[F80Terbutaline sulphate | Inhalation] |
Tetracycline hydrochloride | External use or oral |
Tretinoin | External use |
Triamcinolone acetonide | External use, aural, nasal or oral paste |
Trimethoprim | Oral |
Tuberculin PPD | Parenteral |
Vaccine, Adsorbed Diphtheria | Parenteral |
Vaccine, Adsorbed Diphtheria And Tetanus | Parenteral |
Vaccine, Adsorbed Diphtheria And Tetanus For Adults And Adolescents | Parenteral |
Vaccine, Adsorbed Diphtheria For Adults And Adolescents | Parenteral |
Vaccine, Adsorbed Diphtheria, Tetanus And Pertussis | Parenteral |
Vaccine, Adsorbed Diphtheria, Tetanus And Pertussis (Acellular Component) | Parenteral |
Vaccine, BCG | Parenteral |
Vaccine, BCG Percutaneous | Parenteral |
Vaccine, Haemophilus Influenzae Type B (Hib) | Parenteral |
Vaccine, Haemophilus Influenzae Type B (Hib) with Diphtheria, Tetanus And Pertussis | Parenteral |
Vaccine, Haemophilus Influenzae Type B, Diphtheria, Tetanus And Acellular Pertussis | Parenteral |
Vaccine, Hepatitis A | Parenteral |
Vaccine, Hepatitis A With Typhoid | Parenteral |
Vaccine, Hepatitis A, Inactivated, With Recombinant (DNA) Hepatitis B | Parenteral |
Vaccine, Hepatitis B | Parenteral |
Vaccine, Influenza | Parenteral |
Vaccine, Live Measles, Mumps And Rubella (MMR) | Parenteral |
Vaccine, Meningococcal Group C Conjugate | Parenteral |
Vaccine, Meningococcal Polysaccharide A and C | Parenteral |
Vaccine, Pneumococcal | Parenteral |
F90. . . | F90. . . |
Vaccine, Poliomyelitis, Live (Oral) | Oral |
Vaccine, Rubella, Live | Parenteral |
Vaccine, Tetanus, Adsorbed | Parenteral |
Vaccine, Typhoid, Live Attenuated (Oral) | Oral |
Vaccine, Typhoid, Polysaccharide | Parenteral |
[F83Water for Injections | Parenteral]] |
Textual Amendments
F80Sch. 3A entries inserted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(g)
F81Words in Sch. 3A inserted (10.12.2003) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2003 (S.I. 2003/2915), arts. 1(1), 3
F82Words in Sch. 3A inserted (4.4.2003) by The Prescription Only Medicines (Human Use) Amendment Order 2003 (S.I. 2003/696), arts. 1(1), 15(a)
F83Words in Sch. 3A inserted (4.4.2003) by The Prescription Only Medicines (Human Use) Amendment Order 2003 (S.I. 2003/696), arts. 1(1), 15(c)
F84Words in Sch. 3A inserted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(a)
F85Words in Sch. 3A substituted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(b)
F86Words in Sch. 3A inserted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(c)
F87Words in Sch. 3A substituted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(d)
F88Words in Sch. 3A substituted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(e)
F89Words in Sch. 3A substituted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(f)
F90Words in Sch. 3A omitted (4.4.2003) by virtue of The Prescription Only Medicines (Human Use) Amendment Order 2003 (S.I. 2003/696), arts. 1(1), 15(b)
Regulation 3B(3)(a)(iii)
Textual Amendments
F91Sch. 3B inserted (4.4.2003) by The Prescription Only Medicines (Human Use) Amendment Order 2003 (S.I. 2003/696), arts. 1(1), 16
A clinical management plan shall contain the following particulars—
(a)the name of the patient to whom the plan relates;
(b)the illnesses or conditions which may be treated by the supplementary prescriber;
(c)the date on which the plan is to take effect and when it is to be reviewed by the doctor or dentist who is a party to the plan;
(d)reference to the class or description of medicinal product which may be prescribed or administered under the plan;
(e)any restrictions or limitations as to the strength or dose of any product which may be prescribed or administered under the plan, and any period of administration or use of any medicinal product which may be prescribed or administered under the plan;
(f)relevant warnings about the known sensitivities of the patient to, or known difficulties of the patient with, particular medicinal products;
(g)the arrangements for notification of—
(i)suspected or known adverse reactions to any medicinal product which may be prescribed or administered under the plan, and
(ii)suspected or known adverse reactions to any other medicinal product taken at the same time as any medicinal product prescribed or administered under the plan; and
(h)the circumstances in which the supplementary prescriber should refer to, or seek the advice of, the doctor or dentist who is a party to the plan.]
Article 8(4)(c)
Ammonium Bromide
Calcium Bromide
Calcium Bromidolactobionate
Embutramide
Fencamfamin Hydrochloride
Fluanisone
Hexobarbitone
Hexobarbitone Sodium
Hydrobromic Acid
Meclofenoxate Hydrochloride
Methohexitone Sodium
Pemoline
Piracetam
Potassium Bromide
Prolintane Hydrochloride
Sodium Bromide
Strychnine Hydrochloride
Tacrine Hydrochloride
Thiopentone Sodium
Article 11(1)(a)
Column 1 | Column 2 | Column 3 |
---|---|---|
Persons exempted | Prescription only medicines to which the exemption applies | Conditions |
1. Persons selling or supplying prescription only medicines to universities, other institutions concerned with higher education or institutions concerned with research. | 1. All prescription only medicines | 1. The sale or supply shall be– (a) subject to the presentation of an order signed by the principal of the institution concerned with education or research or the appropriate head of department in charge of a specified course of research stating– (i) the name of the institution for which the prescription only medicine is required, (ii) the purpose for which the prescription only medicine is required, and (iii) the total quantity required, and (b) for the purposes of the education or research with which the institution is concerned. |
2. Persons selling or supplying prescription only medicines to any of the following– (1) a public analyst appointed under section 27 of the Food Safety Act 1990(2) or article 36 of the Food (Northern Ireland) Order 1989(3), (2) an authorized officer within the meaning of section 5(6) of the Food Safety Act 1990, (3) a sampling officer within the meaning of article 38(1) of the Food (Northern Ireland) Order 1989, (4) a person duly authorized by an enforcement authority under sections 111 and 112, (5) a sampling officer within the meaning of Schedule 3 to the Act. | 2. All prescription only medicines. | 2. The sale or supply shall be subject to the presentation of an order signed by or on behalf of any person listed in column 1 of this paragraph stating the status of the person signing it and the amount of prescription only medicine required, and shall be only in connection with the exercise by those persons of their statutory functions. |
3. Persons selling or supplying prescription only medicines to any person employed or engaged in connection with a scheme for testing the quality and checking the amount of the drugs and appliances supplied under the National Health Service Act 1977(4), the National Health Service (Scotland) Act 1978(5) and the Health and Personal Social Services (Northern Ireland) Order 1972(6), or under any subordinate legislation made under those Acts or that Order. | 3. All prescription only medicines. | 3. The sale or supply shall be– (a) subject to the presentation of an order signed by or on behalf of the person so employed or engaged stating the status of the person signing it and the amount of prescription only medicine required, and (b) for the purposes of a scheme referred to in column 1 in this paragraph. |
4. Registered midwives. | 4. Prescription only medicines containing any of the following substances–
| 4. The sale or supply shall be only in the course of their professional practice and in the case of Ergometrine maleate only when contained in a medicinal product which is not for parenteral administration. |
5. Persons lawfully conducting a retail pharmacy business within the meaning of section 69. | 5. Prescription only medicines which are not for parenteral administration and which– (a) are eyes drops and are prescription only medicines by reason only that they contain not more than 0.5 per cent Chloramphenicol, or (b) are eye ointments and are prescription only medicines by reason only that they contain not more than 1.0 per cent Chloramphenicol, or (c) are prescription only medicines by reason only that they contain any of the following substances:
| 5. The sale or supply shall be subject to the presentation of an order signed by a registered ophthalmic optician. |
6. Registered ophthalmic opticians. | 6. Prescription only medicines listed in column 2 of paragraph 5. | 6. The sale or supply shall be only– (a) in the course of their professional practice and (b) in an emergency. |
7. Persons selling or supplying prescription only medicines to the British Standards Institution. | 7. All prescription only medicines. | 7. The sale or supply shall be– (a) subject to the presentation of an order signed on behalf of the British Standards Institution stating the status of the person signing it and the amount of the prescription only medicine required, and (b) only for the purpose of testing containers of medicinal products or determining the standards for such containers. |
8. Holders of marketing authorizations, product licences or manufacturer’s licences. | 8. Prescription only medicines referred to in the authorizations or licences. | 8. The sale or supply shall be only– (a) to a pharmacist, (b) so as to enable that pharmacist to prepare an entry relating to the prescription only medicine in question in a tablet or capsule identification guide or similar publication, and (c) of no greater quantity than is reasonably necessary for that purpose. |
9. Pharmacists selling or supplying to persons to whom cyanide salts may be sold by virtue of section 3 (regulation of poisons) or section 4 (exclusion of sales by wholesale and certain other sales) of the Poisons Act 1972(7) or by virtue of article 5 (prohibitions and regulations with respect to sale of poisons) or article 6 (exemption with respect to certain sales) of the Poisons (Northern Ireland) Order 1976(8). | 9. Amyl nitrite. | 9. The sale or supply shall only be so far as is necessary to enable an antidote to be available to persons at risk of cyanide poisoning. |
[F9310. F94... registered chiropodists who hold a certificate of competence in the use of the medicines specified in Column 2 issued by or with the approval of the Chiropodists Board [F95or the Health Professions Council]. | 10. The following prescription only medicines— (a)Co-dydramol 10/500 tablets; (b)Amorolfine hydrochloride cream where the maximum strength of the Amorolfine in the cream does not exceed 0.25 per cent by weight in weight; (c)Amorolfine hydrochloride lacquer where the maximum strength of the Amorolfine in the lacquer does not exceed 5 per cent by weight in volume; and (d)Topical hydrocortisone where the maximum strength of the hydrocortisone in the medicinal product does not exceed 1 per cent by weight in weight. | 10. The sale or supply shall be only in the course of their professional practice and (a) in the case of Co-dydramol 10/500 tablets the quantity sold or supplied to a person at any one time shall not exceed the amount sufficient for 3 days' treatment to a maximum of 24 tablets.] |
Textual Amendments
F92Word in Sch. 5 Pt. 1 para. 4 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 4(a)
F93Sch. 5 Pt. 1 para. 10 inserted (13.2.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1998 (S.I. 1998/108), art. 1, Sch.
F94Word in Sch. 5 Pt. 1 para. 10 omitted (9.7.2003) by virtue of The Health Professions Order 2001 (Consequential Amendments) Order 2003 (S.I. 2003/1590), art. 1, Sch. para. 21(3)(a)(i)
F95Words in Sch. 5 Pt. 1 para. 10 inserted (9.7.2003) by The Health Professions Order 2001 (Consequential Amendments) Order 2003 (S.I. 2003/1590), art. 1, Sch. para. 21(3)(a)(ii)
Article 11(1)(b)
Column 1 | Column 2 | Column 3 |
---|---|---|
Persons exempted | Prescription only medicines to which the exemption applies | Conditions |
1. Royal National Lifeboat Institution and certified first aiders of the Institution. | 1. All prescription only medicines. | 1. The supply shall be only so far as is necessary for the the treatment of sick or injured persons in the exercise of the functions of the Institution. |
2. The owner or the master of a ship which does not carry a doctor on board as part of her complement. | 2. All prescription only medicines. | 2. The supply shall be only so far as is necessary for the treatment of persons on the ship. |
3. Persons authorized by licences granted under regulation 5 of the Misuse of Drugs Regulations to supply a controlled drug. | 3. Such prescription only medicines, being controlled drugs, as are specified in the licence. | 3. The supply shall be subject to such conditions and in such circumstances and to such an extent as may be specified in the licence. |
4. Persons requiring prescription only medicines for the purpose of enabling them, in the course of any business carried on by them, to comply with any requirements made by or in pursuance of any enactment with respect to the medical treatment of their employees. | 4. Such prescription only medicines as may be specified in the relevant enactment. | 4. The supply shall be– (a) for the purpose of enabling them to comply with any requirements made by or in pursuance of any such enactment, and (b) subject to such conditions and in such circumstances as may be specified in the relevant enactment. |
5. Persons operating an occupational health scheme. | 5. Prescription only medicines sold or supplied to a person operating an occupational health scheme in response to an order in writing signed by a doctor or a registered nurse. | 5. — (1) The supply shall be in the course of an occupational health scheme. (2) The individual supplying the prescription only medicine, if not a doctor, shall be a registered nurse acting in accordance with the written instructions of a doctor as to the circumstances in which prescription only medicines of the description in question are to be used in the course of the occupational health scheme. |
6. The operator or commander of an aircraft. | 6. Prescription only medicines which are not for parenteral administration and which have been sold or supplied to the operator or commander of the aircraft in response to an order in writing signed by a doctor. | 6. The supply shall be only so far as is necessary for the immediate treatment of sick or injured persons on the aircraft and shall be in accordance with the written instructions of a doctor as to the circumstances in which prescription only medicines of the description in question are to be used on the aircraft. |
7. Persons employed as qualified first-aid personnel on offshore installations. | 7. All prescription only medicines. | 7. The supply shall be only so far as is necessary for the treatment of persons on the installation. |
Article 11(2)
Column 1 | Column 2 | Column 3 |
---|---|---|
Persons exempted | Prescription only medicines to which the exemption applies | Conditions |
1. F96... registered chiropodists who hold a certificate of competence in the use of analgesics issued by or with the approval of the Chiropodists Board [F97or the Health Professions Council]. | 1. Prescription only medicines for parenteral administration that contain,as the sole active ingredient, not more than one of the following substances–
| 1. The administration shall be only in the course of their professional practice. |
2. Registered midwives. | 2. Prescription only medicines for parenteral administration containing any of the following substances but no other substance specified in column 1 of Schedule 1 to this Order– | 2. The administration shall be only in the course of their professional practice and in the case of Promazine hydrochloride, Lignocaine and Lignocaine hydrochloride shall be only while attending on a woman in childbirth. |
3. Persons who are authorized as members of a group by a group authority granted under regulations 8(3) or 9(3) of the Misuse of Drugs Regulations to supply a controlled drug by way of administration only. | 3. Prescription only medicines that are specified in the group authority. | 3. The administration shall be subject to such conditions and in such circumstances and to such extent as may be specified in the group authority. |
4. The owner or master of a ship which does not carry a doctor on board as part of her complement. | 4. All prescription only medicines that are for parenteral administration. | 4. The administration shall be only so far as is necessary for the treatment of persons on the ship. |
5. Persons operating an occupational health scheme. | 5. Prescription only medicines for parenteral administration sold or supplied to the person operating an occupational health scheme in response to an order in writing signed by a doctor or a registered nurse. | 5. — (1) The administration shall be in the course of an occupational health scheme. (2) The individual administering the prescription only medicine, if neither a doctor nor acting in accordance with the directions of a doctor, shall be a registered nurse acting in accordance with the written instructions of a doctor as to the circumstances in which prescription only medicines of the description in question are to be used in the course of the occupational health scheme. |
6. The operator or commander of an aircraft. | 6. Prescription only medicines for parenteral administration which have been sold or supplied to the operator or commander of the aircraft in response to an order in writing signed by a doctor. | 6. The administration shall be only so far as is necessary for the immediate treatment of sick or injured persons on the aircraft and shall be in accordance with the written instructions of a doctor as to the circumstances in which prescription only medicines of the description in question are to be used on the aircraft. |
7. Persons who are, and at 11th February 1982 were, persons customarily administering medicinal products to human beings by parenteral administration in the course of a business in the field of osteopathy, naturopathy, acupuncture or other similar field except chiropody. | 7. Medicinal products that are prescription only medicines by reason only that they fall within the class specified in article 3(c) (products for parenteral administration). | 7. The person administering the prescription only medicine shall have been requested by or on behalf of the person to whom it is administered and in that person’s presence to use his own judgement as to the treatment required. |
8. Persons employed as qualified first-aid personnel on offshore installations. | 8. All prescription only medicines that are for parenteral administration. | 8. The administration shall be only so far as is necessary for the treatment of persons on the installation. |
9. Persons who hold a certificate of proficiency in ambulance paramedic skills issued by, or with the approval of, the Secretary of State [F101or persons who are [F102registered] paramedics]. | 9. The following prescription only medicines for parenteral administration– (a) Diazepam 5 mg per ml emulsion for injection; (b) Succinylated Modified Fluid Gelatin 4 per cent intravenous infusion; (bb) [F103medicines containing the substances Ergometrine Maleate 500mcg per ml with Oxytocin 5 iu per ml, but no other active ingredient] (d) prescription only medicines containing one or more of the following substances, but no active ingredient–
| 9. The administration shall be only for the immediate, necessary treatment of sick or injured persons and in the case of a prescription only medicine containing Heparin Sodium shall be only for the purpose of cannula flushing. |
Textual Amendments
F96Word in Sch. 5 Pt. 3 para. 1 omitted (9.7.2003) by virtue of The Health Professions Order 2001 (Consequential Amendments) Order 2003 (S.I. 2003/1590), art. 1, Sch. para. 21(3)(b)(i)(aa)
F97Words in Sch. 5 Pt. 3 para. 1 inserted (9.7.2003) by The Health Professions Order 2001 (Consequential Amendments) Order 2003 (S.I. 2003/1590), art. 1, Sch. para. 21(3)(b)(i)(bb)
F98Words in Sch. 5 Pt. 3 substituted (13.2.1998) by The Prescription Only Medicines (Human Use) Amendment Order 1998 (S.I. 1998/108), arts. 1, 5(2)
F99Words in Sch. 5 Pt. 3 para. 1 inserted (16.9.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 1998 (S.I. 1998/2081), arts. 1(1), 4(b)
F100Words in Sch. 5 Pt. 3 para. 2 inserted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 4
F101Words in Sch. 5 Pt. 3 para. 9 added (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 5(a)
F102Word in Sch. 5 Pt. 3 para. 9 substituted for words (9.7.2003) by The Health Professions Order 2001 (Consequential Amendments) Order 2003 (S.I. 2003/1590), art. 1, Sch. para. 21(3)(b)(ii)
F103Words in Sch. 5 Pt. 3 para. 9 inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 5(b)
F104Words in Sch. 5 Pt. 3 para. 9 inserted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 5(c)
F105Words in Sch. 5 Pt. 3 para. 9 inserted (1.6.1998) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1998 (S.I. 1998/1178), arts. 1(1), 3
Article 16(1)
Column 1 | Column 2 |
---|---|
Orders | References |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Order 1983 | S.I. 1983/1212 |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1984 | S.I. 1984/756 |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1986 | S.I. 1986/586 |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1987 | S.I. 1987/674 |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment (No. 2) Order 1987 | S.I. 1987/1250 |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1988 | S.I. 1988/2017 |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1991 | S.I. 1991/962 |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1992 | S.I. 1992/1534 |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment (No. 2) Order 1992 | S.I. 1992/2937 |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1993 | S.I. 1993/1890 |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment (No. 2) Order 1993 | S.I. 1993/3256 |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1994 | S.I. 1994/558 |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment (No. 2) Order 1994 | S.I. 1994/3016 |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment (No. 3) Order 1994 | S.I. 1994/3050 |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1995 | S.I. 1995/1384 |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment (No. 2) Order 1995 | S.I. 1995/3174 |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment Order 1996 | S.I. 1996/1514 |
The Medicines (Products other than Veterinary Drugs) (Prescription Only) Amendment (No. 2) Order 1996 | S.I. 1996/3193 |
Articles 12A to 12C
Textual Amendments
F106Sch. 7 inserted (9.8.2000) by The Prescription Only Medicines (Human Use) Amendment Order 2000 (S.I. 2000/1917), arts. 1(1), 2(e)
(a)the period during which the Direction shall have effect;
(b)the description or class of prescription only medicine to which the Direction relates;
(c)whether there are any restrictions on the quantity of medicine which may be supplied on any one occasion, and, if so, what restrictions;
(d)the clinical situations which prescription only medicines of that description or class may be used to treat;
(e)the clinical criteria under which a person shall be eligible for treatment;
(f)whether any class of person is excluded from treatment under the Direction and, if so, what class of person;
(g)whether there are circumstances in which further advice should be sought from a doctor or dentist and, if so, what circumstances;
(h)the pharmaceutical form or forms in which prescription only medicines of that description or class are to be administered;
(i)the strength, or maximum strength, at which prescription only medicines of that description or class are to be administered;
(j)the applicable dosage or maximum dosage;
(k)the route of administration;
(l)the frequency of administration;
(m)any minimum or maximum period of administration applicable to prescription only medicines of that description or class;
(n)whether there are any relevant warnings to note, and, if so, what warnings;
(o)whether there is any follow up action to be taken in any circumstances, and, if so, what action and in what circumstances;
(p)arrangements for referral for medical advice;
(q)details of the records to be kept of the supply, or the administration, of medicines under the Direction.
Column 1 | Column 2 |
---|---|
Class of person by whom a prescription only medicine is supplied or administered | Person on whose behalf the Direction must be signed |
Common Services Agency | The Agency |
[F107Strategic Health Authority] | [F107The Strategic Health Authority] |
Health Authority | The Health Authority |
Special Health Authority | The Special Health Authority |
NHS trust [F108or NHS foundation trust] | The trust |
Primary Care Trust | The Trust |
A person who supplies or administers a prescription only medicine pursuant to an arrangement made with the Common Services Agency, a Health Authority, a Special Health Authority, an NHS trust, [F109, an NHS foundation trust] or a Primary Care Trust | The Common Services Agency, where the arrangement has been made with the Agency; or the Health Authority, Special Health Authority, NHS trust [F110or NHS foundation trust] or Primary Care Trust with which the arrangement has been made] |
Textual Amendments
F107Words in Sch. 7 Pt. 2 inserted (1.10.2002) by The National Health Service Reform and Health Care Professions Act 2002 (Supplementary, Consequential etc. Provisions) Regulations 2002 (S.I. 2002/2469), reg. 1, Sch. 1 para. 73(4)
F108Words in Sch. 7 Pt. 2 inserted (1.4.2004) by The Health and Social Care (Community Health and Standards) Act 2003 (Supplementary and Consequential Provision) (NHS Foundation Trusts) Order 2004 (S.I. 2004/696), arts. 1(1)(b), 3(2), Sch. 2
Textual Amendments
F111Sch. 7 Pt. 2A inserted (4.4.2003) by The Prescription Only Medicines (Human Use) Amendment Order 2003 (S.I. 2003/696), arts. 1(1), 17
Column 1 Force or service by whom or on whose behalf the health care is provided | Column 2 Person by whom or on whose behalf the Direction must be signed |
---|---|
A police force in England or Wales | The chief officer of police for that police force (within the meaning of the Police Act 1996) |
A police force in Scotland | The chief constable of that police force (within the meaning of the Police (Scotland) Act 1997) |
The Police Service of Northern Ireland | The Chief Constable of the Police Service of Northern Ireland |
The prison service in England and Wales | The governor of the prison in relation to which the health care in question is being provided |
The prison service in Scotland | The Scottish Prison Service Management Board |
The prison service in Northern Ireland | The Northern Ireland Prison Service Management Board |
Her Majesty’s Forces | (i)the Surgeon General, (ii)a Medical Director General, or (iii)a chief executive of an executive agency of the Ministry of Defence] |
Textual Amendments
F112Words in Sch. 7 Pt. 3 heading substituted (16.11.2000) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2000 (S.I. 2000/2899), arts. 1(1), 3(2)
[F113Registered paramedics or individuals who hold a certificate of proficiency in ambulance paramedic skills issued by, or with the approval of, the Secretary of State.]
Pharmacists.
Registered health visitors.
Registered midwives.
Registered nurses.
Registered ophthalmic opticians.
[F114Registered] chiropodists.
[F115Registered orthoptists.
Registered physiotherapists.
Registered radiographers.]]
Textual Amendments
F113Words in Sch. 7 Pt. 3 substituted (9.7.2003) by The Health Professions Order 2001 (Consequential Amendments) Order 2003 (S.I. 2003/1590), art. 1, Sch. para. 21(4)(a)
F114Word in Sch. 7 Pt. 3 substituted (9.7.2003) by The Health Professions Order 2001 (Consequential Amendments) Order 2003 (S.I. 2003/1590), art. 1, Sch. para. 21(4)(b)
F115Words in Sch. 7 Pt. 3 substituted (9.7.2003) by The Health Professions Order 2001 (Consequential Amendments) Order 2003 (S.I. 2003/1590), art. 1, Sch. para. 21(4)(c)
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: